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1. Abstract 
 
In eukaryotic cells, microtubules are one of the components of the cytoskeleton and 
are involved in vital processes like migration, cell polarity, mitosis, differentiation 
and intracellular trafficking. Alpha-tubulin, one of the building blocks of 
microtubules, is subjected to the tubulin tyrosination / detyrosination cycle, in which 
the C-terminal tyrosine residue of this protein is removed by a not yet characterized 
tubulin carboxy peptidase and subsequently re-added by tubulin tyrosine ligase 
(TTL). In this study, the influence of tubulin tyrosination on the localization of 
proteins that are specifically localized to the growing microtubule plus ends, the so-
called microtubule plus end tracking proteins (+TIPs) was analyzed. By using RNAi 
knock-down of +TIPs in mouse embryonic fibroblasts (MEFs), we found that 
depletion of one of the most prominent +TIPs (i.e. EB1) leads to a TTL-dependent 
dislocalization of the CAP-Gly domain-containing proteins CLIP-115 and CLIP-170 
from the microtubule plus ends (MT +ends). CLIP-170, the best studied member of 
the CLIPs, was removed from microtubule plus ends in both TTL wild type and TTL 
knock-out cells upon EB1 knock-down. In contrast, CLIP-115, a close homolog of 
CLIP-170 lacking the C-terminal zinc-binding domain, was found to be dislocalized 
from microtubule plus ends only in wild type and not in TTL-deficient EB1-depleted 
cells. This distinct CLIP-115 behavior could be rescued when TTL was reconstituted 
in TTL knock-out EB1-depleted MEFs. The observed difference in CLIP-115 MT 
+end binding is not caused by the lack of the C-terminal domain, since CLIP-170 
mutant proteins lacking this domain localized to MT +ends similarly in both wild 
type and TTL-deficient MEFs. Analysis of microtubule binding of CLIP-115/170 
hybrid proteins pointed to a possible role of coiled coil region in the apparent 
difference in CLIP-115 binding to microtubules. Furthermore, TTL deficiency leads 
to changes in dynamics of microtubules. By using mCherry-α-tubulin a decrease in 
microtubule shrinking speed as wells as an increase in the time microtubule spent 
pausing and a decrease in the time microtubule spent growing was observed. In 
addition TTL-deficiency resulted in increased levels of RhoA activity and a decrease 
of Rac1 and Cdc42 activity. Finally, the lack of TTL did not show any influence on 
the expression level of the RhoA effector mDia1.  
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Taken together, this study shed more light on the molecular mechanisms how 
microtubule plus end tracking proteins localize to microtubules and contributed to 
better understanding the role of the TTL cycle in microtubule dynamics.       
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2. Introduction  
 
2.1. Cytoskeleton and Microtubules  
The cytoskeleton is involved in many critical cellular processes, such as cell 
migration, mitosis, cell polarity and intracellular trafficking. There are three 
cytoskeleton components in eukaryotic cells – actin filaments, intermediate filaments 
and microtubules (Fig. 1). Whereas intermediate filaments mostly confer strength and 
a mechanical stress resistance in a cell, actin filaments and microtubules adapt and 
maintain cell shape. The assembly of cytoskeletal networks occurs via incorporation 
of small building molecules into filamentous or tubular polymers. Intermediate 
filaments polymerize through assembly of antiparallel dimers into oligomers that 
generate apolar filaments. The assembly of actin filaments and microtubules, in 
contrast, occurs by a head-to-tail incorporation of actin and respectively αβ-tubulin 
dimers, that results in polar fibres that hydrolyze phosphate bonds of ATP on actin 
filaments or GTP on microtubules. The polarized nature and dynamic properties of 
these two cytoskeletal systems allow cells to generate asymmetry, which can be 
recognized for instance in structurally different ends of both actin- and microtubule 
polymers.  
In this work I have focused on microtubules (MTs), which are important for widely 
different processes, such as mitosis, cell migration, intracellular trafficking and 
neuronal differentiation. MTs are hollow cylindric tubes built from of α- and β-
tubulin heterodimers (Fig. 1 and 2). Under in vitro conditions, growing MTs exhibit 
different behaviors. They can either polymerize or depolymerize on each end and the 
net growth depends on free tubulin concentrations (5). Above a certain tubulin 
concentration microtubules polymerize until most of the tubulin is in the form of a 
polymer, whereas below this concentration they undergo a switch-like behaviour 
known as dynamic instability, e.g. switching between phases of growth and shrinkage 
(1-4, 15). The transition from growth to shrinkage is called “catastrophe”, whereas 
the switch from shrinkage to growth is called “rescue”. 
Basic microtubule bulding blocks are composed of a very stable tubulin heterodimers. 
The αβ−tubulin heterodimers assemble into protofilaments which form a hollow fibre 
of polar parallel protofilaments. Helical pitch of the 12 nm radius together with the 8 
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nm-long repeat between α- and β-tubulin subunits creates a lattice seam along the 
microtubule filament (3 – 5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Schematic representation and cellular distribution of the cytoskeleton. 
Left panel – electron microscopic pictures and schematic drawings of three components of 
the cytoskeleton: microtubules, actin filaments and intermediate filaments, Right panel – 
intracellular organization of cytoskeleton in eukatyotic cells (Adapted from the website 
available by following the enclosed links)  
 
Microtubule assembly and disassembly is a dynamic process that consumes and 
releases energy. It requires binding, hydrolysis and exchange of guanine nucleotide 
GTP on β-tubulin (note that GTP bound to α-tubulin is non-exchangeable and is not 
hydrolysed). GTP-β-tubulin is hydrolysed to GDP shortly after assembly and this is 
promoted by the locking of the partially exposed GTP nucleotide, as a result of the 
head-to-tail assembly of tubulin dimers (1, 3, 4). In this case, due to conformational 
changes, α-tubulin acts as a GTPase leading to GTP hydrolysis on the β-tubulin in the 
heterodimer (1, 3, 4). When the GTP dissociation rate is lower than a certain 
concentration of free GTP-β-tubulin, the addition of new GTP-β-tubulin subunits 
catches up and exceeds GTP dissociation leading to the formation of a so-called GTP-
cap at the growing tip of the microtubule (1, 3, 4, 8). It has been postulated that GTP 
hydrolysis changes the conformation of the protofilament from a slightly curved 
GTP-tubulin to a more profoundly curved GDP-tubulin structure (6). This nucleotide-
dependent, conformational model predicts that the curved GDP-tubulin stays straight 
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when it is part of the microtubule wall, thus growing microtubule sheets are believed 
to maintain the GTP-cap to stabilize straight tubulin conformation within the 
microtubule lattice. Under conditions when GTP-tubulin hydrolysis is higher than the 
cytoplasmic GTP-tubulin concentration, straight tubulin conformation is no longer 
maintained and the microtubule depolymerizes rapidly (1, 3, 4, 8). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Structural representation of a tubulin heterodimer and a microtubule filament. 
α− and β-tubulin that bind GTP nucleotides (red) form stable heterodimers (A) that assemble 
in a head-to-tail fashion into protofilaments (B). 13 protofilaments build one microtubule (C). 
In panel (D) a transmission electron microscopic picture of an assembled microtubule is 
shown. (Adapted from Molecular Biology Of The Cell, B. Alberts & others, 4th edition) 
 
Growing and shrinking microtubules, visualized by cryo-electron microscope have 
differently structured ends. Growing microtubules appear as curved sheets, whereas 
shrinking microtubules are characterized by fountain-like fraying arrays of 
protofilaments (9, 10, Fig. 3). When the assembled tubulin subunits are converted into 
GDP-tubulin, the new GTP-tubulin subunits can be incorporated at the plus end, so 
the already bound GDP-tubulin subunits undergo “treadmilling” through the 
microtubule (1, 3, 4, 8). Due to structural differences of both microtubule ends, rate 
constants that govern growth and shrinkage are different at the opposite ends. As a 
consequence, the addition of free tubulin subunits occurs preferentially at the plus end 
of microtubule. The minus end of microtubules is very often embedded in the 
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microtubule organizing centre (MTOC), a structure which is tightly linked to the 
centrosome (7) and prevents depolimerization from the minus end (8). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Growing and shrinking microtubules. Schematic structures (lower panels) and 
electron microscopic pictures (upper panel) of growing and shrinking microtubules. GTP 
bound tubulin (red) forms a GTP-cap which protects the microtubule from depolymerization. 
After loosing the GTP-cap, exposed GDP-bound tubulin leads to unstable polymer 
conformations resulting in microtubule depolymerization. (Adapted from Molecular Biology Of 
The Cell, B. Alberts & others, 4th edition) 
 
An important component of the centrosome is γ-tubulin, which is an unusual form of 
tubulin, believed to initiate nucleation by forming rings that serve as templates for 
new microtubule growth (13, 14). If the minus end is not embedded, the dissociation 
of GDP-tubulin can take place also at these ends. Microtubules can be assembled in 
two structurally different polymers known as type A and B with different lateral 
contacts between the protofilaments. The typical lattice form, which is thought to be 
predominant in most of the cell types, is the B lattice containing lateral contacts of αα 
and ββ subunits resulting in one seam with αβ subunit contacts. There is however an 
increasing number of evidence showing that microtubule associated proteins could 
drive microtubules into the lattice A in which all lateral contacts are between αβ 
subunits (11).           
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2.2. Organization of cytoskeleton networks in different model systems 
Microtubules in different model systems can be differently organized. This is related 
to unique cell morphologies in organisms varying from yeast to mammals. For 
instance in budding yeast, new daughter cells are formed from the mother cells at the 
so-called bud neck (Fig. 4a).  
 
               
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Organization of microtubules in different model systems. MTOC – microtubule 
organizing center, +TIP – microtubule plus end tracking proteins, C – central region, T – 
transition zone, P – peripheral region, A – astral microtubules, B – kinetochore microtubules, 
C – interpolar microtubules, growing microtubules shown in red, shrinking microtubules – 
green, stable microtubules – blue. For details see text. (Adapted from Galjart 2005; Nature 
reviews, Molecular Cell Biology 6)  
 
Microtubules emanating from one spindle pole are guided by a Bim1-Kar9-myosin-
dependent pathway into the bud. Dynein located at the microtubule plus end is 
important for “reeling in” the nucleus at the bud cortex (18). In fission yeast, 
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microtubule arrays grow out from the cell center (Fig. 4b). When microtubules 
approach the cell membrane, microtubule plus end tracking proteins (+TIPs) ensure 
that they grow until they reach the periphery of the cell, where they undergo 
catastrophe and shrink back (18).  
Soil-born fungi such as Aspergillus nidulans represent a filamentous growth, meaning 
that in the multinucleated filament nuclei migrate towards the tip, in a process that 
depends on microtubules and the dynein-dynactin complex. Microtubules 
interconnect the nuclei along the entire length of the fungi filament and they reach the 
filament tip with their growing plus ends (18, Fig. 4c). 
The polarity of migrating cells with a ruffling leading edge (e.g. the lamellipodium) 
and a contractile tail, is reflected by the polarized organization of the cytoskeleton. In 
most mammalian cells microtubules are usually arranged with the minus end located 
near the center of the cell or anchored at the MTOC, which is often positioned facing 
the leading edge. The plus ends of microtubules emanate radially towards the leading 
edge, where they explore the cell cortex (17, Fig. 4d). Actin filaments are arranged 
with growing plus “barbed” ends subadjacent to the plasma membrane and with the 
minus “pointed” ends directed towards the cell interior. In the lamellipodium, actin 
forms a dendritic network. In contrast, the tip of filopodium is devoid of microtubules 
and actin filaments are arranged in parallel bundles (19). Actin polymerization at the 
leading edge is balanced by a myosin-driven rearward movement of the 
lamellipodium actin network, called retrograde flow (20). Behind the lamellipodium, 
the actin meshwork moves in the direction of the cell front and creates so called 
“convergence zone” where retrograde and anterograde actin movements come across 
(21, 22) (Fig. 5). At this site, due to the presence of myosin-2, high contractility is 
observed (23) and actin filament disassembly prevails (21). To induce the movement 
of the cell, the traction through the contractile actin bundles is generated, which is 
accompanied by pulling on focal adhesion contacts attached to the substrate. Focal 
adhesions are then assembled at the cell front and disassembled at the rear-end of the 
cell (24). 
Neurons are composed of the cell body, the axon and several shorter dendrites that all 
spread radially from the cell body. In dendrites the microtubules are organized in 
apolar bundles whereas in axons they are polar. The growth cones are formed at the 
tip of the axon and are divided into peripheral, transition and central regions (40). 
Microtubules emanate from the cell body through the axon and grow into the growth 
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cone (18, Fig. 4e). Large bundles of stable microtubules prevail in the central domain, 
whereas dynamic microtubules penetrate the peripheral region of the growth cone 
with their growing plus ends. The transition zone is located between the central and 
peripheral region and contains contractile actin bundles oriented perpendicular to 
filopodia. Like in migrating cells, actin retrograde flow occurs in lamellipodia at the 
leading edge of the growth cone (Fig. 6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Organization of microtubules and actin network in a migrating cell. LA – 
lamellipodium, CZ – convergence zone. Microtubules shown in green, myosin – blue dots, F-
actin – red. See text for details. (Adapted from Rodriguez et al. 2003; Nature Cell Biology 5)    
  
Dynamic microtubules polymerize into the growth cone periphery where actin 
filaments serve as guides, along which microtubules grow into the growth cone 
extensions (41 – 43). Microtubules are at the same time cleared from the growth cone 
periphery by depolymerization or by coupling to actin retrograde flow, which enables 
microtubule turnover within the growth cone. Microtubles that are caught by the 
retrograde flow and move rearward, are very often buckled, they bend and finally 
break exposing unstable minus ends and new plus ends in the transition zone (41). 
Contractile actin bundles that predominate in the transition zone also interact with 
microtubules and by transverse movements, transport them into the central region of 
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the growth cone. The microtubules present in the transition zone are less dynamic 
than those associated with filopodia (21).  
In dividing cells microtubules form the mitotic spindle which is composed of astral, 
kinetochore, and interpolar microtubules (Fig. 4f). Growing and shrinking 
microtubules can have various structures bound to their ends and this is thought to 
allow shrinking microtubules to exert forces on associated structures, such as 
kinetochores (12). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Organization of microtubules and actin in the neuronal growth cone. C-central 
region, T-transition zone, P-peripheral region. Filopodial parallel actin structures shown in 
red, actin meshwork in periphery – black, contractile actin bundles – blue, unbundled 
microtubules – green, less dynamic microtubules – brown, bundled microtubules – light 
brown. For details see text. (Adapted from Rodriguez et al. 2003; Nature Cell Biology 5)  
 
Two microtubule asters that are organized by the sister MTOCs interlock themselves 
into an antiparallel array and connect with kinetochores on replicated sister 
chromosomes to separate them equally into daughter cells.  
                                  
2.3. Interactions of microtubules with the actin cytoskeleton 
In vitro and in vivo studies have already shown that in migrating cells the 
organization of microtubules is strongly influenced by the actin cytoskeleton. The 
first evidence came from the observation that microtubules are transported rearward 
in the lamella of the motile cells and that this is dependent on the actomyosin 
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machinery (25 – 27). Fluorescent Speckle Microscopy revealed that microtubules are 
coupled to actin retrograde flow in the lamella and to anterograde actin movement in 
the cell body (21, 23), and that microtubules can also grow along actin filaments and 
are often dragged through the cytoplasm by their connection to the moving actin 
bundles (21), (Fig. 5, panel 1). ACF7, a member of the spectraplakin family of 
cytoskeletal crosslinking proteins, that possesses both actin and microtubule binding 
domains, is proposed to be an essential integrator of microtubule-actin dynamics. 
Studies on ACF7 null endodermal cells showed that in the absence of ACF7 
microtubules no longer grow along polarized actin bundles, nor do they pause and 
bind to actin-rich cortical sites (57). Microtubules can also target focal adhesions by 
crosslinking to and growing along focal adhesion associated actin bundles, leading to 
disassembly of focal adhesions, which is mediated by dynamin and focal adhesion 
kinase (FAK) (21, 44, Fig. 5, panel 2). The plus ends of microtubules might also be 
anchored at the cell cortex through the interactions between +TIPs and actin-binding 
proteins to orientate MTOC towards the direction of cell movement (Fig. 5, panel 3). 
Moreover, it is reported that MTOC reorientation is mediated by the small Rho 
GTPase, Cdc42 and the microtubule motor dynein. It has been suggested that 
microtubule plus ends are crosslinked to the actin cortex, at specific sites defined by 
Cdc42, leading to pulling forces and thereby moving the MTOC in front of the 
nucleus by cytoplasmic dynein (45 – 47).  
Interactions between actin and microtubules can be controlled through diverse 
regulatory mechanisms. The mechanism involving the Rho family of small GTPases 
is so far best understood. RhoA for instance not only mediates the formation of 
contractile actin structures, the so-called stress fibres (28), but also promotes 
stabilization of microtubule sub-populations (29). Two key factors are known to act 
downstream of RhoA. One of them is Rho kinase, which promotes contractility by 
increasing phosphorylation of the regulatory light chain of myosin-2 (30). Secondly, 
mDia, a member of the formin protein family, promotes actin polymerization into 
bundles (31, 32) and additionally mediates microtubule stabilization (33). Specifically 
mDia1 appears as a coordinator of microtubules and the actin cytoskeleton. In HeLa 
cells it induces bipolar elongation, aligning microtubules in parallel to actin bundles 
along the longer axis of the cell (58). Another small GTPase, Rac1, also regulates 
both actin and microtubule polymerization, leading to promotion of lamellipodial 
protrusion (34, 35). Rac1 controls actin cytoskeleton dynamics through the 
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Scar/WASP protein pathway, which activates Arp2/3-dependent assembly of actin 
networks and through PAK kinases that regulate actin treadmilling on the leading 
edge via the ADF/cofilin pathway (30, 34, 35). PAK kinases can additionally promote 
microtubule growth by regulating the microtubule destabilizing protein 
Op18/stathmin (35, 36). Actin and microtubules can, in turn, also regulate the activity 
of small Rho GTPases. Microtubule and actin disassembly activates RhoA (37), 
whereas microtubule assembly stimulates Rac1 activity (38). Depolymerizing 
microtubules are believed to release the microtubule-bound Rho guanine nucleotide 
exchange factor (GEF) GEF-H1, which then activates RhoA (39). Although the 
pathway by which microtubule growth leads to Rac1 activation is still obscure, recent 
findings revealed the involvement of adenomatous polyposis coli (APC) protein in 
this process. APC protein is localized to growing microtubule ends in lamellipodial 
protrusions (49, 50) and binds the Rac1 specific GEF ASEF, which stimulates 
lamellipodia formation and cell migration (51, 52). Loss of APC results in 
disappearance of cellular protrusions and decreased cell migration (53). Another 
interesting candidate to mediate the microtubule growth-mediated Rac1 activation is 
IQGAP1, which forms a common complex together with Rac1, Cdc42, APC and 
actin and additionally binds to microtubule plus ends through CLIP-170 (54, 55). 
Moreover, disruption of the interactions between IQGAP1, Rac1 and Cdc42 leads to 
diminished lamellipodial activity (54). 
 
2.4. Microtubules and intracellular transport 
Due to their large size and complexity, eukaryotic cells need to ensure directional, 
effective transport and distribution of various kinds of cellular components to their 
proper destination in the cell. This is very important not only for cellular 
morphogenesis but also for proper targeting of organelles and proteins to distinct 
compartments within the cell, especially in highly polarized and differentiated cells, 
such as epithelial cells or neurons. Once assembled, polarized arrays of microtubules 
provide tracks for the transport of proteins, organelles and protein-containing 
vesicular cargoes (16). For this transport, eukaryotic cells use motor proteins that 
walk along microtubule tracks. There are two classes of microtubule associated motor 
proteins: kinesins (59) and dyneins (60). Kinesins (except for kinesin-14 family 
members) move in the direction of the microtubule plus end thereby ensuring 
anterograde transport which goes from the cell center to peripheral cellular regions. 
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All dyneins discovered so far move towards the microtubule minus end providing 
retrograde transport from the cell periphery to the cell interior.  
Kinesins are present in all eukaryotic cells and are involved in fast axonal transport in 
neurons, in organization of the cytoplasm during interphase, in directional vesicle 
movement within the cell and in cell division. Kinesins are tetramers composed of 
two heavy and two light chains with typical molecular weights of ~ 110 – 130 and ~ 
60 – 80 kDa, respectively (61). Kinesins are ATPases and most of them possess N-
terminal motor domain that includes the ATP binding site and microtubule binding 
regions. They move towards microtubule plus ends with a velocity of about 1 µm/s 
making 8 nm long steps, that correspond to the spacing between tubulin dimers in 
protofilaments (62, 63). Some unconventional kinesins, like the above mentioned 
kinesin-14, have a C-terminal motor domains which enable minus end directed 
movement of the molecule (64). Finally, some kinesins do not move cargo but instead 
bind specifically to the microtubule plus ends resulting in microtubule destabilization 
(65).  
Dyneins are microtubule motors that rely on energy from ATP hydrolysis to move 
along microtubules with velocities above 2 µm/s. The majority of vertebrate dyneins 
are axonemal motors involved in flagellar or ciliary movements, whereas the 
cytoplasmic dyneins are involved in retrograde transport of vesicles and organelles, 
mitotic spindle organization and chromosome segregation (60). Cytoplasmic dyneins 
move usually towards microtubule minus ends but they can also move laterally across 
the microtubule surface and even anterogradely. Dyneins consist of one to three 
heavy chains (~ 500 kDa), which possess the AAA-type ATPase motor domain and 
various intermediate domains and light chains. Although dyneins can directly interact 
with other proteins such as Lis1 (66), most of the interactions are mediated by 
accessory subunits. Dynein together with dynactin works as a part of a multiprotein 
complex, of which the main role is the orientation of the mitotic spindle and nuclear 
migration. Dynactin is a dynein cofactor, that increases dynein’s processivity and is 
involved in most types of dynein activity (67). The dynein/dynactin complex has been 
resolved and showed to have the structure of a “shoulder-side arm”, so that the 
“shoulder” provides binding to microtubules via the large dynactin subunit p150Glued 
and the “side arm” connects the entire complex to the transported vesicles (18).                                   
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2.5. Tubulin posttranslational modifications  
In most eukaryotic cells, microtubules acquire several evolutionary conserved 
posttranslational modifications that principally affect the C-terminus of α-tubulin and 
in some cases β-tubulin. These modifications that include detyrosination, generation 
of ∆2-tubulin, acetylation, phosphorylation, palmitoylation, polyglutamylation and 
polyglycylation contribute to the generation of functional diversity of microtubules 
and may play a role in recruiting specific protein complexes. The precise generating 
mechanism and functional role of posttranslational modifications in regulation of 
microtubule structure are not yet fully understood, however it has been proven that 
most of these modifications occur on stable microtubules and they are thought to be 
involved in their stabilization. 
 
2.5.1. Tyrosination / detyrosination  
The reactions of tyrosination and detyrosination of microtubules are a part of the 
tyrosination / detyrosination cycle which is conserved in most eukaryotic cells (108, 
109, Fig. 7). Since the C-terminal tyrosine is encoded by the α-tubulin messenger 
RNA, the primary modification in the tyrosination / detyrosination cycle to occur is 
α-tubulin detyrosiantion. This involves the enzymatic removal of the C-terminal 
tyrosine residue from α-tubulin by a so far poorly characterized tubulin tyrosine 
carboxypeptidase (TTCP) (110). Detyrosination takes place preferably on 
polymerized microtubules resulting in exposition of C-terminal glutamic acid on α-
tubulin, that is often referred to as Glu-tubulin (111). Although the identity of the 
tubulin carboxypeptidase is still unknown, novel cytosolic carboxypeptidases have 
been identified. NNA1/CCP1 belongs to a family of six related genes and is present 
in tissues containing high amount of tubulin, such as testis and brain (112). 
Detyrosination seems to be important, as mice with deleted NNA1/CCP1 lack 
detyrosinated α-tubulin in the olfactory bulb and show degeneration of Purkinje cells. 
These mice also show notable movement disabilities (112).  
The reverse reaction that converts soluble, depolymerized Glu-tubulin back to its 
tyrosinated status (Tyr-tubulin) is carried out by the tubulin tyrosine ligase (TTL), a 
globular monomeric enzyme with a molecular mass 43 kDa (113). TTL shows 
preference for free tubulin subunits and does not appear to tyrosinate tubulin within 
microtubules (114). In vitro, the enzyme can also catalyze the C-terminal 
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incorporation of phenyloalanine and modified tyrosines, such as fluoro- and iodo-
tyrosine (133, 134). Purification of TTL was first described by Murofushi et al. (126) 
and after generation of monoclonal anti-TTL antibodies, sufficient amounts of the 
TTL enzyme were purified by immunoaffinity (113). Sequence analysis proved that 
TTL belongs to the group of glutathione-synthetase ADP-forming enzymes, which 
possess an ATP-dependent ligase activity (127). Interestingly, the TTL sequence 
appears to be present only in mammalian and trypanosome genomes, although 
detyrosination is widely spread among eukaryotes (115). In cell cultures Glu-tubulin 
is enriched in stable microtubules, whereas Tyr-tubulin is exclusively found in 
dynamic microtubules (119 – 121). Tubulin detyrosination however, is regarded to be 
rather a consequence and not the cause of microtubule stabilization (122). In cells 
with very long-lived microtubules, removal of the penultimate glutamic acid results in 
the formation of ∆2-tubulin, which is no longer a substrate for TTL and escapes the 
TTL cycle (116, 117). Since ∆2-tubulin is a marker for long-lived microtubules, 
stable ∆2-tubulin containing microtubules can principally be found in neurons but can 
also appear in cells lacking TTL activity (118). Furthermore, it has been described 
that most of the tyrosinated brain tubulin is polyglutamylated as well, and brain ∆2-
tubulin is specifically polyglycylated suggesting a certain degree of coordination 
between distinct postranslational modifications (123).  
 
 
 
 
 
 
 
 
 
 
 
Figure 7. The tubulin tyrosination / detyrosination cycle. Newly translated tyrosinated 
tubulin dimers assembled in microtubules undergo detyrosiantion by a poorly characterized 
tubulin tyrosine carboxypeptidase (TTCP). After microtubule disassembly tubulin dimers are 
tyrosinated by tubulin tyrosine ligase (TTL). ∆2-tubulin, which additionally lacks the 
penultimate glutamic acid residue, can not be tyrosinated and escapes the cycle. (Figure 
provided by Marco van Ham)    
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Although a physiological significance of the tyrosination cycle has not been well 
demonstrated, in recent years some important functions of tubulin tyrosination have 
been discovered. In human and animal cancer models TTL happens to be often 
suppressed during tumor growth, giving an indication that TTL loss and tubulin 
detyrosination confers selective advantage for cancer cell proliferation (124). At least 
in mammals, TTL turns out to be essential for neuronal organization, as TTL 
suppression in mice leads to lethal disorganization of neuronal circuits (125). Brain 
anatomy investigation in TTL null mice showed blurring of cortical layers with a 
reduced number of cells in the cortical plate zone. Also a disruption of the cortico-
thalamic loop in the brain of TTL null mouse embryos was noticed. This disruption 
most probably accounts for the early death of new-born mice. Accordingly, cultured 
TTL null neurons showed morphogenetic anomalies involving an accelerated and 
erratic time course of neurite and axon outgrowth, significantly higher axonal and 
neuritic growth rate, and premature axonal differentiation (125). It has also been 
published that tubulin tyrosination can have influence on different recruitment of 
microtubule plus end binding proteins (+TIPs) (see also chapter 2.6.). Proteins, such 
as CLIP-170, CLIP-115 and p150Glued, +TIPs that contain a cytoskeleton-associated 
protein glycin-rich (CAP-Gly) microtubule binding domain, have been shown to be 
localized to the ends of tyrosinated microtubules but not to detyrosinated 
microtubules. The localization of other +TIPs, such as EB1, MCAK and CLASP2 
was not affected by microtubule detyrosination. These changes in localization of 
+TIPs also correlated with defects in spindle positioning during cell division and with 
abnormal cell morphology during interphase (128). The tyrosination / detyrosination 
cycle is also reported to influence differential recruitment of the microtubule motor 
protein kinesin-1. It has been shown that kinesin-1 binds preferentially to 
detyrosinated microtubules and that this could enable a preferential movement of 
various cargoes, including vimentin filaments and transferin along detyrosinated 
microtubules (129 – 132). Very recently, tubulin tyrosination has been shown to drive 
motor-dependent microtubule disassembly. In fibroblasts, tubulin detyrosination 
inhibits MT disassembly and this inhibition is relieved by overexpression of the 
depolymerizing motor mitotic centromere-associated kinesin (MCAK). Suppression 
of MCAK expression prevents disassembly of tyrosinated microtbubules. 
Detyrosination of microtubules also suppresses MCAK activity in vitro (135). Some 
indications for the possible involvement of Glu-tubulin in the initiation of myogenic 
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differentiation are also apparent. Nitrotyrosine, which can also be incorporated into 
α-tubulin by TTL, has been used to suppress the detyrosiantion of microtubules and 
resulting in arrested differentiation of myoblasts into mytotubes (136 – 138). It is also 
proven that during muscle cell differentiation the plus end binding protein EB1, 
which is necessary for microtubule stabilization, is required for proper differentiation, 
elongation and fusion of myotubes (139). These processes are also accompanied by 
the appearance of Glu-tubulin in early events that precede differentiation, suggesting 
a possible role of stable microtubules in muscle differentiation processes (139, 140).                                                    
    
2.5.2. Glutamylation and glycylation 
Glutamylation and glycylation occur both on α- and β-tubulin C-terminal ends (68, 
69). Glutamylation is present in neurons, centriols, axonemes (cilia and flagella), and 
mitotic spindles, whereas glycylation prevails mostly in the axonemes. These two 
modifications can be present on the same C-terminal tail and a cross-talk between α- 
and β-tubulin tails that regulates the level and type of each modification is present 
(70, 71). Both modifications turned out to be reversible reactions, however, the 
enzymes responsible for the reverse reactions are poorly characterized.      
In polyglutamylated microtubules, an up to 20 residues-long polyglutamylate side 
chain is added to the γ-carboxylate group of glutamate in the C-terminal tubulin tail 
via an isopeptide bond (72, 73). Biochemical studies have shown that 
polyglutamylation can involve multiple neighbouring amino acid residues (74, 75). 
The enzymes catalyzing tubulin glutamylation have been recently described. They 
belong to the tubulin tyrosine ligase-like (TTLL) family of enzymes containing a 
specific TTLL domain at the catalytic region, which is similar to the tubulin tyrosine 
ligase (TTL) domain. Some of the TTLL domain-containing enzymes have been 
reported to be glutamylases with different α- and β-tubulin specificities and different 
chain-initiating or chain-elongating activities (76 – 78). Many experiments have 
proven an essential role of polyglutamylation in the formation and maintenance of the 
axonemal structure (79). There is also an increasing number of evidence for 
polyglutamylation to influence the interactions between microtubules and 
microtubule associated proteins (MAPs). Kinesin and tau have been shown to exert 
stronger affinity for microtubules that are polyglutamylated with relatively short 
glutamic-acid side chains (80 – 82). Additionally centrioles in non-neuronal cells are 
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extensively polyglutamylated which has been found to occur on early stages of 
centriole genesis. Microinjection of specific antibodies recognizing polyglutamylated 
sites on microtubules in HeLa cells resulted in centriole disappearance and loss of the 
entire centrosome (83 – 84). These examples imply thus a main role of 
polyglutamylation in centriole maturation and stability.  
In polyglycylated microtubules, similarly to polyglutamylation, a polyglycine side 
chain is covalently attached through an isopeptide bond to glutamate residues of the 
C-terminus of both α- and β-tubulin. This modification can involve the addition of an 
up to 34 glycine residue-long side chain and is mainly present in mammalian sperm 
tubulin (85, 86). Also, like in the case of polyglutamylation, multiple glutamate 
residues can be subjected to polyglycilation (87). The enzymes catalyzing 
polyglycylation are poorly described. Recently, it has been found that TTLL10, which 
is known as a polyglacylase for nucleosome assembly protein 1, can also perform 
tubulin glycylation (227). Another protein TTLL3 has also been identified as a 
tubulin glycine ligase which regulates the assembly of cilia (228). Polyglycylation 
occurs extensively and predominantly in axonemal tubulins in primitive eukaryotes, 
like Tetrahymena. This organism provided the most detailed functional analysis of 
polyglycylation so far. It has been shown that in this cialiate protozoa, 
polyglycylation is important for the axonemal organization, ciliary motility and 
cytokinesis (88).                   
                    
2.5.3. Acetylation / deacetylation 
Acetylation occurs only on the ε-amino group of the conserved lysine 40 residue at 
the N-terminus of α-tubulin (89, 90). This modification is present mostly in axonemal 
structures and on stable microtubules after microtubule assembly (91). Acetylation 
came into existence early during evolution and thus is present in most primitive 
eukaryotes. It is postulated, basing on electron-crystallographic structure, that the 
modified lysine residue resides on the luminal face of microtubules (92, 93). The 
enzyme which carries out the acetylation reaction has not been identified yet, 
however two enzymes have been shown to catalyze the reverse reaction both in vivo 
and in vitro, HDAC6 and SIRT2. HDAC6 belongs to the histone deacetylase family. 
SIRT2 has been described to play a role in transcriptional silencing in yeast. 
Knockdown of either HDAC6 or SIRT2 leads to hyperacetylation of tubulin, 
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suggesting an interdependence in action of each of them (94 – 96). There have been 
indications that acetylation is not essential for cell survival, however it has been 
proven that acetylation of α-tubulin plays a role in motor-based trafficking in 
mammals and that kinesin-1 binds with higher affinity to acetylated microtubules in 
vitro (97, 98). Acetylation is also suggested to be engaged in cell motility processes, 
as an overexpression of HDAC6 leads to increased chemotactic movement of NIH-
3T3 cells and inhibition of HDAC6 abrogated cell migration (94, 99).                  
   
2.5.4. Other modifications  
Phosphorylation  
Tubulin phosphorylation is not wildely observed and its precise function is not well 
understood, however some indications for phosphorylation-dependent regulation of 
tubulins are noteworth. Phosphorylation of a serine residue in the C-terminus of β-
tubulin has been reported to be essential in mouse neuroblastoma differentiation 
although the respective kinase at that time was unknown. Phosphorylation of class III 
β2-tubulin was accompanied by neurite outgrowth that depended on the level of 
phosphorylated β-tubulin in the polymer (100). β-tubulin can additionally be 
phosphorylated at serine 172 residue by Cdk1/cyclin B complex. This 
phosphorylation regulates the entry into mitosis (103). In B lymphocytes, a tyrosine 
residue in the C-terminus of α-tubulin is phosphorylated by the tyrosine kinase Syk, 
which is required for B-cell differentiation (101, 102). Several other kinases have 
been reported to phosphorylate tubulin in vitro but the physiological relevance of 
those events is so far unknown.     
Palmitoylation 
It has been shown that cysteine residue 376 on α-tubulin can incorporate 
radioactively labelled palmitate (105 – 107). It is suggested that palmitoylation could 
play a role in the positioning of astral microtubules and the interactions of 
microtubules with the cell cortex. Mutation of cysteine 376 to serine in the budding 
yeast Saccharomyces cerevesiae reduced the level of palmitoylation by 60% without 
affecting cell division, however some defects in the positioning of astral microtubules 
and an affected spindle translocation through the bud neck have been described (105 - 
107).     
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Methylation 
Recent mass spectrometry studies in the parasite Toxoplasma gondii have detected a 
novel posttranslational modification. Both α- and β-tubulins are C-terminally 
methylated which seems to be specific only for T. gondii, as this modification was not 
detected in the host cells (201).        
                  
2.6. Microtubule plus end tracking proteins 
The dynamics and shape of microtubules are under control of multiple microtubules 
associated proteins (MAPs).  
 
 
Figure 8. Microtubule plus end tracking proteins (+TIPs).  Proteins are grouped according 
to structural elements involved in tracking microtubule plus ends. AAA – ATPase family 
associated with various cellular activities, Arm – armadillo repeats, Basic/Ser – basic/Serine-
rich sequences, CAP-Gly – cytoskeleton associated protein Gly-rich domain, ClipZnF- C-
terminal zinc binding domain, CH – calponin homology, EBH – end-binding protein homology, 
EF-hand – calcium binding motif, GAS2 – growth-arrest-specific protein-2 domain, LISH – 
Lis1 homology domain, SAM – sterile α motif domain, SAMP – Ser-Ala-Met-Pro repeat, TOG 
– tumour-overexpressed gene domain, TM – transmembrane  domain, WD40 – motif of ~40 
aminoacids, often terminating with Trp-Asp dipeptide. Predicted HEAT and TOR repeats in 
CLASP and ezrin-radixin-moesin domain of STIM1 are indicated by dotted lines. (Adapted 
from Akhmanova & Steinmetz 2008; Nature reviews, Molecular Cell Biology )        
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This large group of proteins embrace classic MAPs, which bind along the entire 
length of microtubules, such as molecular motors and non-motor proteins, and 
microtubule plus end tracking proteins (+TIPs). +TIPs are members of a family of 
evolutionary conserved and structurally unrelated proteins that specifically 
accumulate on the growing microtubules plus ends (Fig. 8). 
+TIPs localize to a short stretch of the newly polymerized microtubule. They bind 
only weakly or are totally absent from the rest of the microtubule. All +TIPs possess 
characteristic structures and microtubule-binding regions (Fig. 8). They play roles in 
the regulation of microtubule dynamics, interactions of microtubules with the cell 
cortex and kinetochores, as well as in microtubule-mediated transport.  
 
 
 
Figure 9. Mechanisms of microtubule plus end tracking. Schematic drawing of multiple 
mechanisms of microtubule plus end tracking: co-polymerization, lateral diffusion, kinesin 
based transport, hitchhiking and the recognition of specific structures are depicted in panel 
(a), treadmilling and the rapid exchange model are shown in (b). For details see text. 
(Adapted from Akhmanova & Steinmetz 2008; Nature reviews, Molecular Cell Biology) 
 
Malfunction of these proteins leads to several human diseases, such as 
neurodevelopmental disorders and mental retardation. +TIPs, due to their specific 
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localization, turned out to be a useful tool for visualizing the dynamic behavior of 
microtubules in various cell types, like neurons and fibroblasts.     
The molecular mechanisms leading to the specific targeting of +TIPs to growing 
microtubule plus ends and signaling pathways by which +TIPs regulate cellular 
dynamics are still poorly understood and are subject of intensive studies (196). The 
most current models predict that +TIPs recognize a specific structure at the growing 
microtubule end or copolymerize with tubulin (Fig. 9). After incorporation, +TIPs 
might be immobilized at the plus ends until the structure is shaped into the closed 
microtubule lattice and then +TIPs would be dissociated as microtubule treadmilling 
proceeds (152, see chapter 2.1.). Alternatively, +TIPs might undergo fast exchange at 
specific binding sites on microtubule ends. These binding sites would then disappear 
over time during microtubule lattice maturation (196, Fig. 9b).  
There are different possibilities how +TIPs could reach the microtubule plus end. 
First, they could arrive at the plus ends by diffusion either in the cytoplasm or along 
the microtubule lattice. Secondly, +TIPs can be transported to microtubule plus ends 
by kinesins or by the other binding partners, a mechanism which is known as 
hitchkiking. Finally, +TIPs could also accumulate at the plus ends by co-
polymerization with microtubule dimers or oligomers (152, Fig. 9a). 
 
2.6.1. EB family of proteins 
The evolutionary conserved EB family of end binding proteins encompasses three 
mammalian members EB1, EB2 (RP1), EB3. They share a conserved domain 
structure with high sequence homology and their orthologues are present in plants and 
fungi (141). All EB proteins play a common role in sustaining microtubule dynamics 
by increasing rescue frequencies and decreasing depolymerization rate, and the time 
microtubule spend pausing (142 – 144). Although functional analyses have been 
mostly restricted to EB1, it looks like distinct EBs can have different cellular 
functions. Recent findings proved that EB1 and EB3, but not EB2 promote persistent 
microtubule growth by suppressing catastrophes (145). Analysis of muscle cell 
differentiation pointed to a specific function of EB3 in regulation of microtubule 
dynamics at the cell cortex and its necessity for myoblast elongation and fusion (146). 
It has also been proven that the interactions discovered for EB1 can be replicated by 
EB3 but not EB2 (151).  
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EBs are small, dimeric proteins which contain an N-terminal calponin homology 
(CH) domain responsible for the interactions with microtubules (147), a linker region 
of unknown function, a C-terminal coiled coil domain required for dimerization (148, 
149) and an acidic tail containing a C-terminal EEY/F sequence, which is important 
for autoinhibition and binding to various other partners (Fig. 8). The coiled coil 
domain of EBs partially overlaps with the unique EB1-like motif, which is referred to 
as the end-binding homology (EBH) domain (148, 149). Through a flexible C-
terminal tail, which is strikingly similar to that of α-tubulin and CLIP-170, EB 
proteins can interact with almost all other known +TIPs recruiting them to growing 
microtubule plus ends (148 – 154).  
EB1, which is the most detail studied member of the EB family was first identified as 
an APC interacting protein and was regarded as an accessory to APC function (155). 
When other interactions of EB1 emerged, it became clear that APC is rather one of 
many cofactors that competitively activate EB1 promoting microtubule growth and 
stability. Given the large variety of possible interactions between the C-terminus of 
EB1 and many other ligands, it is logical to place EB1 in the central core of the 
interactions with other +TIPs (48). Beside the microtubule growth promoting 
properties, EB1 has also been found to be involved in other cellular processes, such as 
cilia formation (156) and muscle cells differentiation (139, see chapter, 2.5.1.). The 
evolutionarily most conserved EB protein interactions take place during cell division. 
It is known that EB1 contributes to spindle positioning by capturing microtubules at 
the cell cortex (157, 158). EB1 is also involved in microtubule anchoring at the 
centrosome (159) and has been implicated in the interactions between microtubules 
and kinetochores (160). Reciprocal interactions between EB1, microtubules and other 
+TIPs will be described in detail in chapter 2.6.5.             
          
2.6.2. Cytoskeleton-associated protein Gly-rich (CAP-Gly) proteins 
CAP-Gly domain-containing proteins play an important role in many cellular 
processes including chromosome segregation, establishment and maintenance of cell 
polarity, intracellular transport, intracellular signaling and tumorgenesis. CLIP-170, 
CLIP-115 and the structurally related large subunit of the dynactin complex p150Glued 
contain a cytoskeleton-associated protein Gly-rich (CAP-Gly) domain at their N-
terminus (Fig. 8). These domains mediate binding to both microtubules and EB 
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proteins (161, 162). Globular CAP-Gly domains are structures with a unique 
hydrophobic cavity encompassing ~ 80 highly conserved amino acid residues. This 
hydrophobic cavity contains the conserved GKNDG sequence motif and several 
characteristic glycine residues that are involved in shaping the loop of the globular 
fold of the CAP-Gly domain (154, 163). Both CLIPs and p150Glued contain flexible 
central coiled coil domains that mediate dimerization and allow intramolecular 
folding back of the protein (162). Furthermore, only CLIP-170 contains the C-
terminal cargo-binding domain with two tandemly repeated zinc binding motifs and 
additionally a C-terminal EEY/F sequence with high similarity to that of EB1 and α-
tubulin. Structural studies have shown that CLIP-170 can fold back on itself, owing to 
the intramolecular interaction between the N-terminal CAP-Gly domain and the C-
terminal zinc-binding domain, creating a closed autoinhibitory conformation (162). 
By that mechanism, CLIP-170 can be protected from other interactions at its both 
ends. CLIP-115 lacks the C-terminal zinc-binding domain and therefore can not be 
folded into an inactive state. CLIP-170 and CLIP-115 share a high degree of 
homology, especially in the N-terminal part of the protein (164).  
CLIP-170 is the first described and best studied member of the CAP-Gly proteins. 
The function of CLIP-170 was originally assigned as being a linker between 
endosomes and microtubules (165) and subsequently was identified as the first +TIP 
(166). Both CLIP-170 and CLIP-115 bind to microtubule plus ends through the 
interactions of the CAP-Gly domains with EB1 or EB3 (167, 150). CAP-Gly domains 
can also bind directly to microtubules via the C-terminal EEY/F motif of α-tubulin. 
CLIP-170 as well as CLIP-115 stabilize microtubules by preventing catastrophes and 
promoting rescue events (168, 169). CLIP-170 is additionally involved in the 
recruitment of the molecular motor dynein to the plus ends (Fig. 10). This recruitment 
depends on the dynactin complex, since the dynactin large subunit p150Glued binds to 
the C-terminal zinc-binding domain of CLIP-170 and additionally binds dynein (170). 
Furthermore, the zinc-binding domain of CLIP-170 also interacts with Lis1, a 
regulator of dynein function (173). CLIP-170 together with dynein is present at the 
kinetochores in dividing cells where the complex may play a role in microtubule 
capturing, since overexpression of the C-terminal part of CLIP-170 displaced the 
endogeneous protein from kinetochores and caused a delay in prometaphase (171, 
172).  
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In addition to CLIP-170, CLIP-115 and p150Glued there are also other, less known and 
not that well characterized CAP-Gly proteins. CLIP-related protein of 59 kDa 
(CLIPR-59) contains two CAP-Gly domains and a palmitoylation membrane-
targeting motif at the C-terminus. CLIPR-59 binds to the trans-Golgi network and to 
the plasma membrane. It is involved in the trafficking from endosome to trans-Golgi 
and possibly regulates microtubule dynamics near certain membrane domains such as 
lipid rafts (174). 
 
 
 
 
Figure 10. A model showing the possible interactions between CLIP-170, dynactin, 
dynein, and LIS1 at the plus end of a growing MT. Free CLIP-170 can adopt a folded 
conformation through an intramolecular interaction of its terminal domains. Binding to MTs 
correlates with the unfolding of CLIP-170, which allows the interaction via the COOH-terminal 
domain with its binding partners, such as p150Glued, resulting in p150Glued/dynactin recruitment 
to the MT +end. Dynactin can subsequently recruit cytoplasmic dynein and LIS1. LIS1 might 
act to release dynactin from the complex with CLIP-170, facilitating microtubule minus end-
directed transport. LIS1 may remain associated with dynein or it may form a transient 
complex with CLIP-170. (Adapted from Lansbergen et al. 2004; J. Cell Biol.) 
 
Another member of the CLIP family, CLIP-4 is poorly characterized and consists of 
three CAP-Gly domains and an ankyrin-repeat-like domains of unknown function 
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(175). Tubulin folding cofactors TBCB and TBCE are the most evolutionarily 
conserved CAP-Gly domain-containing proteins. They participate in tubulin dimer 
biogenesis and turnover, and their CAP-Gly domains are required for stable 
interactions with microtubules (176). 
Also the deubiquitylating tumor-suppressor protein CYLD belongs to the CAP-Gly 
family of proteins. Through its C-terminal catalytic domain, CYLD hydrolyzes 
polyubiquitin chains on different proteins and in that way negatively affects NF-κB- 
and JNK kinase-dependent signaling (177). The role of two other CAP-Gly proteins, 
CAP350 and KIF13B, remains obscure. CAP350 is a large centrosomal protein with 
its single CAP-Gly domain mediating interaction with the Golgi network. CAP350 
additionally stabilizes microtubules and is required for anchoring microtubules to the 
centrosomes (178). KIF13B is a kinesin-3 family member and is involved in the 
transport of the tumor suppressor protein disc large Dlg and PIP3-containing vesicles 
to microtubule plus ends (179).                 
                                      
2.6.3. Proteins containing basic/Serine-rich sequences  
There are several large multidomain microtubule plus end binding proteins containing 
extensive sequence regions, enriched with basic and serine residues. These regions 
are predicted to be very flexible and very often mediate interactions with EB proteins 
and microtubules.  
CLASP proteins 
CLIP-associating proteins CLASPs are a group of microtubule associated proteins 
conserved in animals and fungi and were originally identified as interacting partners 
of CLIPs (180). CLASP1 is ubiquitously expressed in all tissues, whereas CLASP2 
shows highest expression level in the brain. Both CLASPs are regulators of 
microtubule dynamics, bind dynamic microtubule plus ends and stabilize them by 
rescuing them from depolymerization (181). Domain analysis of CLASPs revealed 
the presence of several HEAT repeats (see chapter 2.6.4.) and a region which is rich 
in serine and arginine residues in the middle part of the protein responsible for 
interactions with EB1 and microtubules (18, Fig. 8). The HEAT repeat is located in 
the N-terminal domain which is similar to the Dis1/TOG family of microtubule 
stabilizing proteins. The C-terminal region of both CLASPs is required for the 
interaction with CLIPs, the Golgi-network and the cell cortex (18). CLASP proteins 
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play an essential role in cell division. For instance, CLASP1 is an important 
component of the kinetochore where it regulates spindle microtubule dynamics (182). 
CLASPs also participate in generating polarized microtubule arrays in interphase 
cells (180). CLASPs can bind directly to microtubules as well as to CLIP-170 and 
EB1 (180, 181) and these interactions contribute to the localization of CLASPs at the 
microtubule plus ends. CLASPs association with microtubules is spatially regulated. 
In migrating fibroblasts, CLASPs specifically bind to the microtubule plus ends in 
cortical patches close to the leading edge (180, 184). In epithelial cells, CLASPs bind 
to the MT +ends in the cell body and they also bind preferentially to microtubules in 
the lamella, decorating the entire length of the microtubule lattice. The MT +end 
binding of CLASP in cell body is independent of the microtubule lattice-localization 
of CLASP in the lamella (183). Glycogen synthase kinase 3β (GSK3β) acting 
downstream of Rac1 appears to be a key regulator in binding of CLASPs to 
microtubules (180, 183). GSK3β disrupts the CLASP microtubule association by 
phosphorylation of CLASPs (180, 183). Recent studies in HeLa cells have revealed 
that microtubule plus ends can be attached to the cell cortex via CLASPs with the 
help of LL5β and ELKS in a process that is controlled by phosphatidylinositol-
triphosphate PIP3 (56).  
APC proteins 
Another prominent example of a basic/Serine-rich sequence-containing protein is the 
adenomatous polyposis coli (APC) tumor suppressor (see chapter 2.3.). APC is a 
large multidomain protein implicated in colorectal cancer. Due to truncation 
mutations that delete large region of the C-terminus of APC, deregulation of Wnt 
signaling and disrupted cell proliferation is evident (185). APC is also involved in 
microtubule organization. Loss of APC results in defects in chromosome segregation 
and defects in parallel organization of microtubule arrays (186, 187). The N-terminal 
part of the molecule contains heptad repeats predicted to form coiled coil domains 
involved in oligomerization (190, 192). These heptad repeats contain characteristic 
armadillo repeats, responsible for interactions with many proteins including the 
regulatory subunit of phosphatase 2a (PP2A), APC-stimulated guanine exchange 
factor (ASEF) and kinesin linker protein KAP3 (190, 192). The middle part of the 
APC molecule comprises domain that contains 15/20-residue repeats involved in β-
catenin binding. The binding of β-catenin is regulated by phosphorylation and is part 
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of the WNT signaling pathway (190, 192). The less conserved, C-terminal region of 
APC contains basic/Serine-rich regions mediating interactions with microtubules, 
EB1 and the PDZ domain-containing protein Dlg (190, 192). Detailed domain 
structure of APC is depicted on Figure 8. 
APC localizes at clusters of microtubule plus ends that invade cellular protrusions and 
supports cell migration by local stabilization of microtubules (188). APC association 
with microtubules, similarly to CLASP, is regulated by GSK3β (188). APC-
dependent stabilization of microtubules and promotion of cell migration also depend 
on EB1 binding to APC and the formation of a common complex with mDia, a 
downstream effector of Rho (189). Finally, APC has been observed to associate with 
IQGAP1 at the actin-rich leading edge of the cell, suggesting a role for APC in the 
cross-talk between actin and the microtubule cytoskeleton (55, see chapter 2.3.).  
Other basic/Serine-rich sequences-containing proteins 
To the group of the basic/Serine-rich sequences-containing proteins also belongs the 
broadly expressed microtubule-actin crosslinking factor MACF/ACF7 (see chapter 
2.3.). MACF/ACF7 possesses the ability to bind both actin and microtubule filaments 
(57). This protein contains two calponin homology domains, one plakin domain and 
several small spectrin domains with basic/Serine rich region (Fig. 8). Another 
example of the basic/Serine-rich sequences-containing proteins is the stromal 
interaction molecule 1 (STIM1) which is a microtubule plus end tracker involved in 
remodeling of the endoplasmic reticulum (ER). STIM1 is a transmembrane protein 
essential for the store-operated calcium entry, a process of extracellular calcium 
influx in response to depletion of Ca2+ stores in ER. STIM1 is localized 
predominantly to the ER and when Ca2+ is released from the ER, STIM1 is 
translocated to the ER-plasma membrane junctions actvating Ca2+ channels. STIM1 
binds directly to EB1 and brings the polymerizing microtubules in contact with the 
ER network (192). Other proteins containing basic/Serine-rich sequences are 
melanophilin, neuron navigator-1 and Rho-type guanine nucleotide exchange factor 
RhoGEF2, but will not be explained in more detail here.   
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2.6.4. Other microtubule plus end tracking proteins 
 
HEAT- and WD40-repeat-containing proteins 
The HEAT- and WD40-repeat-containing +TIPs encompass XMAP215 and Lis1 
(Fig. 8). XMAP215 contains tumour-overexpressed gene (TOG) domains at the N-
terminal end, involved in microtubule binding, and comprising several HEAT repeats. 
HEAT repeats are modules containing ~37 – 47 aminoacids, and an array of HEAT 
repeats forms a rod-like structure that participates in protein-protein interactions (193, 
194). XMAP215 is a processive microtubule polymerase which accelerates 
microtubule growth by tenfold. This process is most probably regulated by reducing 
the dissociation of incoming tubulin dimers and stabilizing the GTP cap (193, 194).  
Lissencephaly-1 (Lis1) proteins contain an N-terminal Lis homology (LISH) domain 
and a C-terminal WD40 repeat (195). WD40 repeats consist of a 40-amino acid 
repeat, that forms a characteristic β-propeller structure. WD40 repeats are implicated 
in G protein mediated signal transduction, transcription regulation and vesicle 
formation and trafficking. The WD40 domain of Lis1 is required for targeting to 
CLIP-170 and this interaction also involves recruitment of dynein/dynactin complex. 
(66, 162, see chapter 2.6.2.). Overexpression studies with dynactin and Lis1 indicate 
that these two proteins compete for interaction with the CLIP-170 C-terminus (Fig. 
10). Lis1 might thus act to release dynactin from the complex with CLIP-170, thereby 
facilitating minus end directed transport (162).      
Microtubule motor proteins 
Both plus-end and minus-end directed molecular motors can bind to microtubule plus 
ends. Theoretically, due to their directed movement, all plus-end directed kinesins 
could accumulate at the microtubule plus ends. However, at normal expression levels 
most of them do not show plus-end localization. A prominent example of the plus end 
tracking kinesins is a member of the microtubule depolymerizing kinesin-13 family – 
MCAK (see chapter 2.5.1.). Additionally yeast kinesins Tea2, Kip2 and Kar3 as well 
as Drosophila melanogaster KLP10A are reported to bind to microtubule plus ends 
(152). The accumulation of kinesins and cytoplasmic dyneins at the microtubule plus 
ends usually relies on their association with other +TIPs (152).        
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2.6.5. Reciprocal interactions between microtubules and +TIPs at the cell 
cortex 
Although +TIPs are complex multidomain proteins, the interactions between them 
and microtubule rely on a limited number of protein modules, such as CAP-Gly-,  
CH-, EBH- domains, C-terminal EEY/F motifs and basic/Serine-rich sequences. The 
C-terminal aromatic residue of the EEY/F motif, which is present in EB1 is crucial 
for recruitment and binding of CAP-Gly domains (154). It has been proven that CAP-
Gly domain-containing proteins do not bind to microtubules composed of α-tubulin 
that lacks the C-terminal tyrosine of the EEY/F motif (128). The C-terminal part of 
EB1, in addition to the EEY/F motif also contains an EBH domain that is crucial for 
the interactions with basic/Serine-rich sequences, present in APC and CLASPs 
proteins. Highly conserved residues of the EBH motif form a surface comprising a 
deep hydrophobic cavity and a polar rim. The hydrophobic cavity within the EBH 
domains is thought to function as a binding site where the Ile-Pro motif present in 
basic/Serine-rich domains is anchored (148). This indicates a conserved mode of 
binding of APC and CLASP to EB1, thereby enabling “hitchhiking” of these proteins 
on EB1 (18). It is most likely that many other +TIPs, including CLIPs use a similar 
EB-dependent mechanism to target growing microtubule plus ends. Having two 
interaction motifs at the C-terminus, EB1 proteins seem to be a master integrator of 
the +TIP network assembly. As EB1 tracks microtubule plus ends independently of 
its binding partners, it makes it a common factor in the web of functional interactions 
between several +TIPs (Fig. 11). Since microtubules in many cell types extend from 
the cell center to the cell boundary, it is not surprising that the activity of many +TIPs 
is involved in microtubule-cortical interactions. These interactions involve attachment 
of microtubule plus ends to actin cytoskeleton and plasma membrane, connection of 
microtubules with cortical structures and exertion of pulling forces on the 
microtubule network. Four mechanisms of microtubule-cortical interactions can be 
distinguished (Fig. 11). First, cytoplasmic dynein together with its regulator dynactin 
can pull the plus ends of cortically attached microtubules and make them slide along 
the membrane, thereby contributing to centering the centrosome and positioning the 
mitotic spindle (197, see chapter 2.3.). Due to its direct binding to dynactin, CLIP-
170 can contribute to this dynein function in a process that is regulated by Lis1 (162). 
A second mechanism of microtubule capture at the cell cortex involves APC proteins, 
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which stabilize microtubules and attach them to the cell cortex (189, see chapter 
2.6.3.). Because APC itself does not interact with the cell cortex, it links microtubules 
to cortical regions through actin-binding proteins, such as mDia (in complex with 
EB1) or IQGAP1 (Rac1/Cdc42 effector) (189, 55). Additionally, IQGAP1 can 
capture microtubules through the interaction with CLIP-170 (199), thereby 
connecting first two mechanisms. In addition, APC can attach microtubule plus ends 
to the membrane in an actin-independent mechanism, by binding to the PDZ domain-
containing protein Dlg1 that is associated to the membrane via its PDZ domains 
(200). A third mechanism involves the spektraplakin ACF7, that together with EB1, 
directly links microtubules to actin (see chapter 2.3.). This interaction is regulated by 
mDia (57, 149). The fourth mechanism invovles CLASPs that can attach 
microtubules to the cell cortex through LL5β (see chapter 2.3.) and stabilize them 
with the help of EB1 (56, 181). All above mentioned mechanisms involve interactions 
with EB1 and most of them are regulated by the same signaling molecules such as 
mDia and GSK3β, but whether these pathways can act simultaneously on the same 
microtubules and whether they compete with each other is still not entirely clear.     
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. Cortical interactions of microtubules and +TIPs in mammalian cells.  
Schematic drawing of distinct mechanisms of microtubule association to the cell cortex. For 
details see text. (Adapted from Lansbergen & Akhmanova 2006; Traffic 7)   
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2.7. Role of microtubules in polarity of migrating cells 
Cell polarity is essential for the proper function of many cell types. It can be 
established by the asymmetric distribution of mRNA, proteins, organelles and cell 
functions. Due to their inherent structural polarity actin and microtubule filaments are 
well suited to provide the structural basis for cell polarization. During cell migration 
the microtubule cytoskeleton shows a typically polarized structure. The microtubule 
minus ends are localized at the centrosome in the cell center and the plus ends contact 
the actin-rich leading edge and furthermore target focal adhesions at the rear-end of 
the cell. The first evidence showing that microtubules are involved in regulation of 
cortical polarity came from experiments, in which fibroblasts were treated with 
microtubule depolymerizing drugs which resulted in reduced, unpolarized membrane 
ruffling and lack of directional migration (202). Furthermore, it has been proven that 
microtubules are important for positioning the leading edge of the cell but not for the 
migration itself. The mechanism by which microtubules alter cortical polarity it is not 
well understood, however it has been speculated that the small Rho GTPase Rac1 
could contribute to that process. As already mentioned, microtubules can stimulate 
cortical Rac1 activity and cell migration through IQGAP1 (see chapter 2.3.). It has 
been described that the expression of dominant negative IQGAP1 lacking the Rac1-
binding site leads to a decreased level of active Rac1 and a decreased rate in cell 
migration. Additionally, knock-down of IQGAP1 results in actin depletion from the 
leading edge, reduction of lamellipodia formation and finally a decreased migration 
rate (54, 55, 203). How IQGAP1 stimulates Rac1 to induce polarized cell migration is 
not truly clear, but one model assumes that small amounts of IQGAP1 are transported 
by microtubule plus end-bound CLIP-170 to the cortex at the leading edge, where 
IQGAP1 binds to APC and activates Rac1 (204). Rac1 activity can also be stimulated 
via microtubule-based delivery of guanine nucleotide exchange factors (GEFs) to the 
leading edge. One of them, the PAK4 kinase-associated GEF-H1 (see chapter 2.3.) 
promotes Rac1 activation and thereby lamellipodium formation. In the absence of 
PAK4 or in the absence of microtubules, GEF-H1 activates Rho and promotes stress 
fibers formation (39, 205-207). GEF Trio, another one which shows microtubule-
dependent localization at the leading edge, induces lamellipodia formation by 
activating Rac1 (208). Finally, ASEF (see chapter 2.3.) has not been detected on 
microtubules, however it interacts with APC and is implicated in microtubule-
dependent polarized migration (51, 52).   
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Microtubules may coordinate cell migration not only by delivering GEFs to the sites 
of actin polymerization but also by targeting and destroying focal adhesions at the 
rear-end of the cell (see chapter 2.3.). Microtubules that target focal adhesions can 
disassemble them by a Rho/Rac-depentent pathway that involves FAK and dynamin 
(a component of endocytosis pathway). Dynamin binds to microtubules, and in this 
way, is delivered to the focal adhesions where it triggers their dissociation (44, 204, 
209). Additionally, microtubule-dependent promotion of Rac1-mediated 
lamellipodium formation can also have a positive feedback on microtubule 
stabilization. It is described that Rac1-mediated PAK1 kinase activation results in 
phosphorylation and inactivation of the potent microtubule destabilizer stathmin, 
thereby promoting microtubule stabilization (210). Cell polarization requires the 
formation of a subset of persistently stable microtubules that very often accumulate 
posttranslational modifications (see chapter 2.5.). GSK3β, which can be locally 
inactivated and influence microtubule stability at specific cellular locations, appears 
as an important regulator of microtubule based polarity. Among the many 
GSK3β targets are proteins involved in microtubule stabilization such as CLASPs 
and APC. It is known that active Cdc42 at the leading edge leads to PKC-dependent 
phosphorylation and inactivation of GSK3β, which in turn leads to recruitment of 
APC to microtubule plus ends and microtubule stabilization (211). Also CLASP-
mediated stabilization of peripheral microtubules that likely occurs in the vicinity of 
focal adhesions, may be regulated by local GSK3β inactivation (183, 212). Another 
important source of cellular asymmetry can be derived from centrosome positioning 
between the nucleus and the leading edge, which takes place in many types of 
migrating cells including macrophages, fibroblasts, endothelial cells, astrocytes and 
neurons. This process, which also employs subsets of stable microtubules, involves a 
large variety of signaling factors, such as Cdc42, Par6, PKC and dynein and is nicely 
reviewed by Rong Li and Gregg G. Gundersen (213).  
 
2.8. Goal of this thesis 
The aim of this study was to analyze the localization patterns and behavior of 
microtubule plus end tracking proteins in tubulin tyrosine ligase-deficient mouse 
embryonic fibroblasts. The hierarchy of binding of the numerous +TIPs to 
microtubules and the mutual interactions between them are still poorly understood. 
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Since many possible interactions between the +TIPs and microtubules are possible 
and because microtubules undergo multiple posttranslational modifications that are 
reported to influence MT / +TIPs associations (18, 48, 152), RNA interference has 
been used to shed more light on the mechanisms and the hierarchy of binding of the 
+TIPs in cells lacking tyrosinated microtubules. Recently, it has been reported that 
the localization of CAP-Gly domain-containing proteins is influenced by tubulin 
tyrosination / detyrosination (125, 128). Therefore, it is of great interest to study these 
proteins in more detail. Here we show that two closely related CAP-Gly domain-
containing +TIPs, CLIP-170 and CLIP-115, were found to be differently affected by 
the knock-down of EB1, one of the key-players at the growing microtubule plus end, 
in wild type and TTL-knock out cells. Furthermore, GFP-CLIP-115/170 hybrid 
proteins were employed to get more detailed knowledge about the observed distinct 
MT binding behavior of the CLIPs.  
It is well accepted that all +TIPs are prominent regulators of microtubule dynamics 
(152). Additionally, also the TTL-cycle is implicated to play a role in the dynamicity 
of microtubules, as tyrosinated microtubules are known to be more dynamic (119, 
120). Therefore, the analysis of the dynamic behavior of microtubules in TTL knock-
out cells and additionally in TTL knock-out cells after down regulation of distinct 
+TIPs is of particular interest. In this study, different variants of GFP-labeled α-
tubulin as well as a new microtubule-binding GFP fusion protein are used to measure 
microtubule dynamics. 
However the cross-talk between microtubules and the actin cytoskeleton is not well 
studied, the small Rho GTPases are implicated to play a role in this interplay (28, 45, 
54). Some +TIPs, such as CLIP-170, EB1 and APC can also participate in the 
actin/microtubule cross-talk, mainly at the cell periphery (48, Fig. 11, chapter 2.6.5.) 
Understanding the role of these actin/microtubule-regulating proteins in context of the 
TTL cycle is of great interest. Therefore analyzing the activity levels of the small 
GTPases (RhoA, Rac1 and Cdc42) in wild type and TTL-deficient cells may pinpoint 
a cross section between these two elements of the cytoskeleton. Moreover, the RhoA 
downstream effector mDia1 is known to interact with some +TIPs such as EB1 and 
subsequently is involved in microtubules stabilization (33, 189). As TTL knock-out 
cells do contain more stable detyrosinated microtubules (120) it is interesting to 
examine the expression levels of mDia1 proteins in these cells.
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3. Materials and Methods 
 
3.1. Chemicals 
All chemicals used in this study were purchased from following companies: 
Amersham Bioscience, Biorad, Boehringer Mannheim, Cytoskeleton, Fermentas, 
Finnzymes, Fluka, Invitrogen, Macherey-Nagel, Merck, Milipore, New England 
Biolabs, Pharmacia, Promega, Qiagen, Roche, Sigma-Aldrich and Stratagene  
 
3.2.  Molecular Biology Techniques 
 
3.2.1. Enzymes and reagents for molecular biology 
Enzymes were obtained from New England Biolabs, MBI Fermantas or Roche. T4 
DNA ligase and alkaline phosphatase were from Roche. Phusion Taq DNA 
polymerase was from Finnzymes. Oligonucleotydes were from MWG-Biotech. DNA 
markers were from Eurogentec. 
 
3.2.2. Constructs 
All plasmids and constructs used in this work are listed in Table I. 
 
Table I. List of the plasmids used in this work 
Plasmid Antibiotic 
resistance 
Source 
pcDNA3.1+ Ampicillin Invitrogen 
pcDNA3.1+mCherry-α-tubulin Ampicillin Anna Akhmanova, Rotterdam, The 
Netherlands 
pcDNA3.1+mCherry-α-tubulin∆Y Ampicillin this work 
pEGFP-C1 Kanamycin Clontech 
pEGFP-C1-CLIP-115 Kanamycin Niels Galjart, Rotterdam, The 
Netherlands 
pEGFP-C1-CLIP-170 Kanamycin Niels Galjart, Rotterdam, The 
Netherlands 
pEGFP-C1-CLIP-170-∆C 
 
Kanamycin this work 
pEGFP-C1-MBD Kanamycin Margit Oelke, HZI  
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pEGFP-C2 Kanamycin Clontech 
pEGFP-C2-CLIP-115/170-1 Kanamycin this work 
pEGFP-C2-CLIP-115/170-2 Kanamycin this work 
pEGFP-C2-CLIP-115/170-3 Kanamycin this work 
pEGFP-C2-CLIP-115/170-4 Kanamycin this work 
pEGFP-C2-CLIP-115/170-5 Kanamycin this work 
pEGFP-C2-CLIP-115/170-6 Kanamycin this work 
pEGFP-C2-CLIP-115/170-7 Kanamycin this work 
pEGFP-C2-CLIP-115/170-8 Kanamycin this work 
pEGFP-C2-CLIP-115/170-9 Kanamycin this work 
pEGFP-C2-CLIP-115/170-10 Kanamycin this work 
pSuper.neo+GFP Ampicillin OligoEngine 
pSuper.neo+GFP-EB1A Ampicillin this work 
pSuper.neo+GFP-EB1C Ampicillin this work 
pSuper.neo+GFP-EB1/3A Ampicillin this work 
pSuper.neo+GFP-EB2 Ampicillin this work 
pSuper.neo+GFP-EB3 Ampicillin this work 
pSuper.neo+GFP-CLASP1A Ampicillin this work 
pSuper.neo+GFP-CLASP1B Ampicillin this work 
pSuper.neo+GFP-CLASP2A Ampicillin this work 
pSuper.neo+GFP-CLASP2B Ampicillin this work 
pSuper.neo+GFP-CLIP-115A Ampicillin this work 
pSuper.neo+GFP-CLIP-115B Ampicillin this work 
pSuper.neo+GFP-CLIP-170A Ampicillin this work 
pSuper.neo+GFP-CLIP-170B Ampicillin this work 
pGEX-6p3 Ampicillin Amersham Bioscience 
PGEX-6p3-CLIP-170 Ampicillin Niels Galjart, Rotterdam, The 
Netherlands 
pGEX-6p3-CLIP-115 Ampicillin Niels Galjart, Rotterdam, The 
Netherlands 
pIRES2-EGFP-TTL sense Kanamycin Christian Erck, Marco van Ham, HZI 
pIRES2-EGFP-TTL antisense Kanamycin Christian Erck, Marco van Ham, HZI 
 
The pEGFP-CLIP170-∆C construct was generated as follows. pEGFP-CLIP-170 full 
length construct was digested using BamH1 and XhoI restriction enzymes and the 
resulting ~ 3700 bp fragment lacking the C-terminal ~500 bps was cloned into the 
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pEGFP-C1 plasmid that was previously digested with BglII and SalI enzymes. The 
resulting clones were tested for the presence of the proper inserts using BsrGI and 
BamHI restriction enzymes. 
  
pEGFP-CLIP170/115 hybrid constructs were generated as follows. The 5’-terminal 
fragments of CLIP-115 and CLIP-170 were amplified by the PCR using specific 
primers introducing an EcoRI restriction site at the 5’-terminus. Subsequently, the 5’-
terminal PCR products as well as pEGFP-C2 vector were digested with EcoRI and 
SalI restriction enzymes and ligated. The resulting 5’-terminal intermediate constructs 
were then digested with SalI and BamHI, into which the respective 3’-terminal 
SalI/BamHI digested CLIP-170 and CLIP-115 PCR products were cloned. Obtained 
constructs were verified by sequencing.  
 
The mCherry-α-tubulin-∆Y construct, lacking C-terminal tyrosine on α-tubulin, was 
generated by performing the deletion PCR with specific primers introducing an 
EcoRV restriction site on 5’-terminus and an ApaI on 3’-terminus together with 
deletion of C-terminal tyrosine residue. mCherry-α-tubulin was used as DNA 
template. The resulting PCR product was subsequently digested with EcoRV and 
ApaI enzymes and cloned into mCherry-α-tubulin fragment that was digested with 
EcoRV/ApaI. The generated construct was verified by DNA sequencing. 
 
3.2.3. Primers 
Oligonucleotide primers used in this study were synthesized by MWG-Biotech and 
are listed in Table II.  
 
Table II. List of the primers used in this work 
Number Name Purpose Sequence 5’ to 3’ 
M55 pRSseq sequencing AGGGGAACAGGAGAT 
- PGEX3SQ sequencing AAACCTCTGACACATGCAGCTC 
- PGEX5SQ  sequencing GCCTTTGCAGGGCTGGCAAG 
M62 α-tubulin-EcoRV for cloning CCTCGATATCGAGCG 
M63 α-tubulin-∆Y rev cloning GGTGGATCCTTATTATTCCTCTCC 
M121 α-tubulin-∆Y-ApaI rev cloning GGTGGGCCCTTATTATTCCTCTCC 
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M73 RatE2T567seq rev sequencing TAGAAGGCACAGTCGAGG 
3 Actin for cloning GCACTCTTCCAGCCTTCC 
4 Actin rev cloning AGAAAGGGTGTAACGCAACTAAG 
M153 EB1 for cloning CCGAAGAAACCTCTC 
M154 EB1 rev cloning GGTCCAGGCTGCTTA 
M155 EB2 for cloning TCATCCAGTGGCTCT 
M156 EB2 rev cloning TGATGAGACGGTTCA 
M157 EB3 for cloning ATCCTCGAGCTTAAC 
M158 EB3 rev cloning CTGGCGCCTCCCTCA 
M136 mCLIP-115ATGEcoRI cloning GGCGAATTCATGCAGAAGCCCAGT 
M137 hCLIP-170ATG EcoRI cloning CAGAATTCATGAGTATGCTAAAGCC 
M161 mCLIP-115rev1 cloning AGGTCGACGCGGCTGGGCCG 
M162 mCLIP-115rev2 cloning GAGTCGACGAGACAGTGTTGC 
M163 mCLIP-115rev3 cloning CCGTCGACCTCCTCCTGGACC 
M164 mCLIP-115rev4 cloning GCGTCGACGAGTCTATTCTCAGC 
M165 mCLIP-115rev5 cloning TCGTCGACTGGGGAGTGGCG 
M166 mCLIP-115 stop rev6 cloning CCGGATCCTCAGTGTTTGTCC 
M167 mCLIP115 for1 cloning CCGTCGACAGTGGCCTGCTC 
M168 mCLIP-115 for2 cloning ACGTCGACCTCCAGTCAGGC 
M169 mCLIP-115 for3 cloning AGGTCGACCTGGCCGGGCTG 
M170 mCLIP-115 for4 cloning ATGTCGACCAGGCTGCCGAG 
M171 mCLIP-115 for5 cloning ACGTCGACGGGCCCGAGAGAG 
M172 hCLIP-170 rev1 cloning CGGTCGACCCTGCTGCTCACAG 
M173 hCLIP-170 rev2 cloning TTGTCGACTAGCCTTCTTCGG 
M174 hCLIP-170 rev3 cloning TTGTCGACTTCTTTAATAACTTT 
M175 hCLIP-170 rev4 cloning AAGTCGACAATCTGTTTCTCAG 
M176 hCLIP-170 rev5 cloning TGGTCGACACTTGCATTTTCAT 
M177 hCLIP-170 stop rev6 cloning AGGGATCCTCAGAAGGTTTCGTC 
M178 hCLIP-170for1 cloning GCGTCGACCCCAGTCGGACAG 
M179 hCLIP-170for2 cloning GAGTCGACGAGTCCAATAAGC 
M180 hCLIP-170for3 cloning TTGTCGACAAGGAAAACAGTC 
M181 hCLIP-170for4 cloning AAGTCGACAAACATTTAGAGATT 
M182 hCLIP-170for5 cloning ATGTCGACTTTCTGCAAAAAAG 
M183 hCLIP-170rev3-2 cloning AGGTCGACCCTGATGGCTTCCAG 
M93 mCLIP-115seq1 sequencing GTGGAATCCCTCACG 
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M94 mCLIP-115seq2 sequencing TCAGGCACCACAGC 
M96 mCLIP-115seq4 sequencing AAGCCATCGAGTTCC 
M100 mCLIP-115seq3a sequencing TGGCAGACCTCAAGG 
M122 hCLIP-170seq1 sequencing CTCCGATCAGCAACC 
M123 hCLIP-170seq2 sequencing GGAACGGGATCTGG 
M124 hCLIP-170seq3 sequencing TTCCGAAGGTAAATCG 
M125 hCLIP-170seq4 sequencing TGAAGGAGCATTTTGG 
M126 hCLIP-170seq5 sequencing GAAACAAGCCACAACC 
M127 hCLIP-170seq6 sequencing GCAGATGAAGAGAAAGC 
 
3.2.4. Polymerase chain reaction (PCR) 
Polymerase chain reactions were performed for cloning the mCherry-α-tubulin∆Y 
and pEGFP-CLIP115/170 constructs and additionally for examining expression levels 
of EB1, EB2, and EB3 in mouse embryonic fibroblasts (MEFs). The 
oligonucleotides, which were used as primers are listed in Table II. DNA 
amplification using PCR is based on repeated cycles of denaturing the template DNA 
by breaking down the hydrogen bonds at high temperatures, cooling down to anneal 
the primers and increasing the temperature to optimal conditions of DNA synthesis by 
a DNA polymerase. The reactions were done using the proofreading DNA 
polymerase Pfu (Pyrococcus furiosus) in a T3 Biometra thermocycler. Reaction 
temperatures and extension time were adapted to appropriate melting temperature that 
depends on the primer sequence and on the length of the DNA fragment to be 
amplified, respectively. A typical PCR program used in this study is given as an 
example.  
 
  
 
 
 
 
 
 
 
 
PCR mix:  
DNA template (~100ng)  1 µl 
5’ primer  (10 pmol)    5 µl 
3’ primer  (10 pmol)    5 µl 
dNTPs 20 pmol/nucelotide  2 µl 
5x PCR HF buffer   10 µl 
DNA polymerase (2-3U/µl)  0.5 µl 
H2O sterile    27 µl 
Program: 
98ºC 120 s 
98ºC 30 s 
50ºC 30 s         35 cycles 
72ºC 90 s 
72ºC 10 min 
4ºC    ∞   
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3.2.5. DNA sequencing    
DNA sequencing was performed by MWG-Biotech AG (Ebersberg, Germany) or 
GATC company (Konstanz, Germany). Primers used for sequencing are listed in 
Table II. For constructs sequenced by GATC company, sequencing reactions were 
performed according to BigDye Kit (Applied Biosystems) protocol: 
 
PCR mix: 
DNA   0.5 µg 
Primer 3.2 pmol  0.15 µl 
5x sequencing buffer  1 µl 
BigDye reagent  2 µl    
H2O sterile            up to 10 µl    
  
3.2.6. DNA digestion and purification 
Restriction enzyme digestions were performed using the following protocol: 
 
DNA  2 µl (~0.5 - 2 µg) 
Restriction enzymes       0.2 µl each (10U/ µl) 
enzyme buffer 2x                            2 µl 
H2O sterile                                      up to 10 µl 
 
Reaction mixtures were incubated for 1h at 37ºC. Different enzymes required 
different digestion buffers that were provided by the producer. In case of a 
preparative digest, the amounts of the enzymes, buffer and water were appropriately 
increased. Resulting DNA fragments were column purified or separated using agarose 
gel electrophoresis, extracted from agarose gel and then column purified by using the 
PCR clean-up and gel extraction kit (Macherey-Nagel) according to manufacturer’s 
protocol. Briefly, DNA fragments excised from agarose gels were dissolved in double 
amount of NT buffer (200 µl NT buffer / 100 mg agarose) at 50ºC. PCR products 
were diluted in double amount of NT buffer (200 µl NT buffer / 100 µl DNA). The 
DNA was then loaded on the column and centrifuged for 1 minute at 11000 x g. The 
column was washed with 600 µl NT3 washing buffer by centrifugation for 1 minute 
at 11000 x g. The supernatant was discarded and the column was dried by 
Program: 
95ºC 5 min 
95ºC 15 s 
50ºC 15 s           25 cycles 
62ºC 4 min 
72ºC 10 min 
4ºC    ∞   
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centrifugation for 2 minutes at 11000 x g. The DNA was eluted from the column by 
adding 15 – 50 µl elution buffer NE or sterile H2O and spinning down for 1 minute at 
11000 x g. 
 
3.2.7. DNA ligation 
The ligation of DNA inserts into vector DNA was carried out using T4 DNA ligase 
from Roche according to a standard protocol as described below: 
 
Vector DNA                                      50-400 ng 
Insert DNA                                       1:1, 1:2, 1:3, 1:5 molar ratio of vector/insert DNA 
10x ligation buffer                            2 µl    
T4 DNA ligase                                 1 µl 
H2O sterile                                        up to 20 µl    
 
Reaction mixtures were incubated 12 – 16 hours at room temperature and 
subsequently used for transformation (as described in chapter 3.2.8.). 
 
3.2.8. Generation of competent E.coli   
In order to achieve highly efficient transformation, competent Escherichia coli 
bacteria were generated as follows: bacteria were plated on a LB-plate without 
antibiotics and cultured overnight at 37ºC. Fifty ml of LB-medium was inoculated 
with 1 colony and incubated at 37ºC while shaking, until OD550 reached 0.8 – 1.0.  
After that, bacteria were spun down for 10 minutes at 4000 rpm, the resulting pellet 
was resuspended in 1 ml of cold 0.1 M CaCl2 and an additional 4 ml 0.1 M CaCl2 was 
added. Bacteria were then spun down for 10 minutes at 4000 rpm at 4ºC and the pellet 
was resuspended in 5 ml cold 0.1 M CaCl2 . After that, bacteria were put on ice-cold 
water for 25 – 30 minutes, spun down for 10 minutes at 4000 rpm and finally the 
pellet was resuspended in 500 µl 0.1 M CaCl2 containing 14% glycerol. Bacteria were 
alliquoted in 25 µl portions and immediately frozen in liquid nitrogen. Competent 
bacteria were stored at -70ºC.   
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3.2.9. Transformation of E.coli 
Transformation is based on the DNA take-up by bacteria and is performed in order to 
amplify DNA in bacteria. To do this, 80 µl 0.1 M CaCl2 was added to the ligation mix 
(described in chapter 3.2.7.) and the mixture was put on ice for 15 minutes. During 
that time competent bacteria cells (see chapter 3.2.8.) were thawed and left on ice for 
10 minutes. Five µl of bacteria were added to the mix and mixed gently by pipetting. 
The resulting mixture was put on ice for 10 minutes. A so-called heatshock was 
applied for 90 seconds at 42ºC and the bacteria were put on ice for an additional 90 
seconds. Then, 800 µl of LB-medium without antibiotics was added and the mixture 
was incubated at 37ºC while shaking. Bacteria were spun down for 4 minutes at 3500 
rpm and the pellet was plated on LB-plates containing the appropriate antibiotics. The 
plates were incubated overnight at 37ºC. 
 
3.2.10.  Plasmid isolation from E.coli 
Plasmid DNA preparations were performed in small amounts (Mini-Prep) for the 
screening of bacterial clones and in higher amounts (Midi-Prep) to get high yield of 
pure plasmid for cloning, transfections and transformations. Purification procedures 
were performed according to the manufacturer’s protocol using Nucleobond plasmid 
purification kits (Macherey & Nagel). Bacterial cultures for mini-preparations were 
incubated overnight at 37ºC while shaking in 2 ml LB medium with the addition of 
the right antibiotics. Bacteria were then spun down for 30 seconds at 11000 x g and 
the pellet was resuspended in 250 µl of resuspension buffer A1. A volume of 250 µl 
of lysis buffer A2 was added and after 5 minutes incubation at room temperature the 
lysis was ceased by the addition of 300 µl neutralization buffer A3. The mixture was 
then centrifuged for 10 minutes at 11000 x g at room temperature and the supernatant 
was loaded on a column followed by centrifugation for 1 minute at 11000 x g. Bound 
DNA was washed with to 50ºC pre-warmed 500 µl of washing buffer AW by 
spinning down the column for 1 minute at 11000 x g. The column was washed again 
with 600 µl of ethanol-based A4 washing buffer and after discarding the flow-through 
the column was centrifuged again for 2 minutes at 11000 x g to completely remove 
ethanol. A volume of 50 µl sterile H2O was applied to the column and DNA was 
eluted by centrifugation for 1 minute at 11000 x g. DNA purity was tested by agarose 
gel electrophoresis and DNA was stored at -20ºC. 
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Bacterial cultures for midi-preparations were inoculated in 100 ml of LB medium 
with antibiotics and incubated overnight 37ºC while shaking. Bacteria were 
centrifuged at 6000 x g for 15 minutes at 4ºC and the pellet was resuspended in 4 ml 
ice-cold resuspension buffer S1. Bacteria were then lysed by the addition of 4 ml lysis 
buffer S2 and after 5 minutes incubation at room temperature the lysis was 
neutralized by adding 4 ml neutralization buffer S3. The mixture was centrifuged at 
12000 x g for 30 minutes at 4ºC and the cleared lysate was loaded on a column which 
was equilibrated with 2.5 ml buffer N2. After DNA binding, the column was washed 
with 10 ml washing buffer N3. Plasmid DNA was then eluted from the column by the 
addition of 5 ml elution buffer N5 and precipitated in 3.5 ml isopropanol. After 
centrifugation at 19000 x g for 30 minutes at 4ºC the pellet was washed with 2 ml of 
70% ethanol and centrifuged at 19000 x g for 10 minutes at room temperature. 
Ethanol was carefully removed and the DNA pellet was dried at room temperature 
and finally dissolved in an appropriate volume of sterile H2O. The plasmid integrity 
was confirmed by agarose gel electrophoresis and stored at -20ºC for further use.   
       
3.2.11. Agarose gel electrophoresis 
For DNA separation 1% and 2% agarose gels were used. 1% or 2% (w/v) agarose in 
Tris-Acetate-EDTA-buffer (TAE)-buffer (2M Tris base pH 7.5, 1M Sodium acetate, 
50 mM EDTA) was dissolved by boiling in a microwave oven, cooled down to 
approximately 50ºC, poured into a chamber and allowed for polymerization. Before 
polymerization, an appropriate amount of the DNA intercalating agent ethidium 
bromide (2 µl / 50 ml of gel) was added to the gel thereby allowing visualization of 
DNA in UV light. The solid agarose was then transferred to a gel chamber filled with 
TAE-buffer. DNA samples were mixed with 5x DNA loading buffer (15 % (v/v) 
Ficoll, 50 mM EDTA pH 8, 0,5 % (v/v) SDS, 2 % (v/v) 50x TAE buffer, 0,05 % 
(w/v) Bromophenol blue, 0,05 % (w/v) Xylencyanol) and loaded into the gel. Smart-
ladder (200 bp – 10000 bp DNA marker Eurogentec) was loaded as a DNA standard 
and the DNA was separated using 70-100 V current for 30 – 60 minutes. 
Subsequently, gels were exposed to UV light and DNA patterns were documented by 
photoimaging (Intas UV-Systeme).  
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3.2.12. DNA quantification 
DNA quantification was performed using the Nanodrop device (Peqlab). 
Quantification is based on the fact that the photometric absorption of DNA in solution 
has a maximum at a wavelength of 260 nm. Blank measurements were done with the 
appropriate elution buffer, e.g. elution buffer or water, and DNA concentrations were 
measured by applying ~1 µl of DNA solution onto the sensor of the Nanodrop device. 
 
3.3.  Bacterial Culture 
  
3.3.1. Media and additives 
 
• LB medium: bacto-crypton     10 g/L 
   bacto-yeast extract   5 g/L 
   NaCl   10 g/L 
 
• SOB medium: bacto-crypton     20 g/L 
bacto-yeast extract  5  g/L 
NaCl   0.6 g/L 
KCl   0.19 g/L 
• SOC medium: SOB medium 
MgCl2   10 mM 
MgSO4  10 mM 
Glucose    2 mM 
 
•  LB plates :  agar in LB medium  0.4 % (w/v) 
• Antibiotics: ampicillin  100 µg/ml  
kanamycin    34 µg/ml 
 
3.3.2. Bacterial strains 
E.coli strain TG2 (Stratagene) was used for cloning and plasmid amplification. 
E.coli strain BL21 (Stratagene) was used for GST-tagged protein expression.  
Bacterial cultures were incubated overnight at 37ºC under 180 rpm agitation. 
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3.4.  Cell Culture, Transfections and Treatments 
 
3.4.1. Media, reagents and plasticware 
Cell culture media and additives were from Gibco, Invitrogen, PAA and Sigma-
Aldrich. Plasticware were obtained from Nunc, Corning and Falcon. Most commonly 
used media are listed below. 
 
• DMEM/F10 medium for MEFs: 
1 volume of DMEM was mixed with 1 volume of F10 
DMEM (Dulbecco’s modified Eagle’s medium) high glucose (4,5 g/L) 
F10 (Nutrient Mixture – Ham) 
FCS lot 047K3395   10% (v/v) 
Glutamine    2 mM 
Pecnicillin/Streptomycin   50 U/ml 
 
• DMEM medium for B16 cells: 
DMEM (Dulbecco’s modified Eagle’s medium) high glucose (4,5 g/L) 
FCS lot PAA clone   10% (v/v) 
Glutamine    2 mM 
Pecnicillin/Streptomycin   50 U/ml 
 
• PBS (pH 7.4): 
NaCl     137 mM 
KCl     2.7 mM 
Na2HPO4 · H2O    10 mM 
• Trypsin-EDTA     
Trypsin    0.05 %  
EDTA     0.53 mM 
 
 
3.4.2. Cell lines 
Multiple wild-type and TTL-deficient MEFs were derived from mouse embryos and 
used in the different experiments. The numbers of the used cell lines are listed in the 
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figure legends. Cells were cultivated at 37 ºC, 5% CO2 and 85% humidity. Cell lines 
used in this study are listed in Table III.  
 
Table III. List of cells used in this work 
Name Organism Type Source 
MEFs WT Mus musculus TTL(+/+) embryonic fibroblasts Erck et al 2005 
MEFs KO Mus musculus TTL(-/-) embryonic fibroblasts Erck et al 2005 
B16-F1 Mus musculus Skin melanoma cells ATTC (CRL-6323) 
 
3.4.3. Transfections 
Transfections of mammalian cells were performed in order to ensure transient 
expression the DNA construct. MEFs and B16 cells were transiently transfected using 
Fugene 6 (Roche) at 50% - 80% confluency according to manufacturer’s protocol. 
Briefly, for 6 well plate, 90 µl Optimem was mixed with 12 µl Fugene 6 and 1 – 2 µg 
DNA, and incubated for 30 minutes at room temperature. The mixture was then 
added dropwise to the cells and cells were cultured for 24 hours. The medium was 
changed and cells were incubated for suitable time depending on the subsequent 
experiments. For transfections that were not performed in 6 well plates, the mixtures 
were scaled according to the protocol.  
 
3.4.4. AlF4 treatment 
Aluminum fluoride treatment was performed to study microtubule organization in 
conditions where all GTPases were (unspecifically) activated. Semiconfluent cells, 
seeded on coverslips were incubated for 20 – 30 minutes at 37ºC and 5% CO2 in a 
mixture of 30 µl 1M NaF and 5 µl 100 mM AlCl2 in 1 ml DMEM/F10. After that, 
AlF4 solution was removed and cells were washed once with PBS. Cells were 
subsequently fixed according to the protocol described in chapter 3.6.1.    
 
3.4.5. Taxol Treatment 
Taxol treatment was performed to stabilize microtubules and to study localization of 
microtubule associated proteins. Cells were treated with 10 µM Taxol (Paclitaxel, 
Sigma) premixed with medium containing 10% FCS. Medium from cells cultured in a 
6 well plate was removed and 0.5 ml of the Taxol-containing medium was added per 
well. Cells were then incubated at 37ºC and 5% CO2 for 30 to 120 minutes. After that, 
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Taxol was removed and cells were washed with PBS and fixed according to the 
protocol described in chapter 3.6.1.    
 
3.4.6. Wound healing experiments
  
 
Wound healing experiments were performed to induce directional migration of cells 
and study the localization of microtubule associated proteins. For wound healing 
experiments cells were seeded on 12 mm coverslips in 24 well plates. Cells were 
washed with PBS and serum-starved overnight. Starved cells were then scratched 
using a yellow tip and the medium was changed to DMEM/F10 with 10% FCS. Cells 
were allowed migrating into the wound for 8 – 16 hours until the wound was about to 
close. Cells were then fixed and subjected to immunofluorescence staining, as 
described in chapter 3.6.1.       
 
3.4.7. RNA interference 
Introduction of double-stranded RNA has proven to be a powerful tool to suppress 
gene expression through a process known as RNA interference. The pSUPER RNAi 
system used in this study provides a mammalian expression vector that directs 
intracellular synthesis of short interfering RNA (siRNA)-like transcripts, which 
interact with mRNA leading to the specific knock-down of the gene of interest. The 
pSuper.neo+GFP vector is used together with a pair of oligonucleotides that contain a 
unique 19-nucleotide sequence derived from the mRNA transcript of the gene 
targeted for suppression. The expressions of GFP proteins allow the identification of 
transfected cells. Constructs containing the specific interfering sequences were 
generated using standard techniques. For that, forward and reverse oligonucleotides 
were annealed and cloned into the pSuper.neo+GFP vector using BglII and HindIII 
restriction enzymes. This resulted in the localization of the forward oligonucleotide at 
the correct position downstream of the H1 promoter TATA box to generate the 
desired siRNA duplex. The resulting transcript applies an intramolecular 
conformation forming a 19–base pair stem-loop structure, that is quickly cleaved in 
the cell to produce a functional double-stranded RNA (dsRNA). Constructs were 
generated to specifically knock-down +TIPs and the used oligonucleotides are listed 
in Table IV. The newly generated pSuper.neo+GFP constructs were verified by 
sequence analysis and transfected into MEFs. 3 – 4 days after transfection, when 
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protein knock-down has occurred, cells were fixed and subjected to 
immunofluorescence using specific antibodies detecting +TIPs.  
 
Table IV. List of the sense sequences used for RNAi oligonucleotide synthesis 
Number Sequence 5’ to 3’ Target  Source 
M1/2 TCTGACAAAGATAGAACAG EB1A Komarova et al., 2005  
M3/4 TTGCCTTGAAGAAAGTGAA EB1B Komarova et al., 2005 
M89/90 CAGACAAGGTCAAGAAACT EB1C Straube et .al., 2007 
M91/92 TGGACATGCTCTTCCCTGG EB1/3A Straube et .al., 2007 
M5/6 GATGAATGTTGATAAGGTA EB2 Komarova et al., 2005 
M7/8 CTATGATGGAAAGGATTAC EB3 Komarova et al., 2005 
M9/10 GGAGAAGCAGCAGCACATT CLIP170A Lansbergen et al., 2004 
M11/12 TGAAGATGTCAGGAGATAA CLIP170B Lansbergen et al., 2004 
M14/15 GGCACAGCATGAGCAGTAT CLIP115A Lansbergen et al., 2004 
M16/17 CTGGAAATCCAAGCTGGAC CLIP115B Lansbergen et al., 2004 
M18/19 GCCATTATGCCAACTATCT CLASP1A Mimori-Kiyosue et al., 2005 
M20/21 GGATGATTTACAAGACTGG CLASP1B Mimori-Kiyosue et al., 2005 
M22/23 GTTCAGAAAGCCCTTGAT CLASP2A Mimori-Kiyosue et al., 2005 
M24/25 GCACTCATTATGACTCCAT CLASP2B Mimori-Kiyosue et al., 2005 
M1/2 corresponds to the pair of sense and antisense oligonucleotides, M1 and M2 that were 
subsequently annealed and cloned into the pSuper.neo+GFP. 
 
3.5.  Biochemical Methods 
 
3.5.1. Cell lysis and protein extraction 
Cells cultured and treated as described in chapter 4 were washed twice with icecold 
1x PBS and then lysed by adding 150 µl lysis buffer per 100 mm dish. Then, cells 
were scraped from the dish using cell scraper followed by 10 minutes boiling at 95ºC. 
Lysates were stored at -20ºC. The recipe for the lysis buffer is given below: 
 
Lysis buffer 
Tris pH 7.5    25 mM 
EDTA     1mM 
EGTA    1mM 
SDS     1%  
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3.5.2. Protein quantification 
Protein concentrations were determined using Micro BC Assay (Uptima) and is based 
on the Biuret reaction using bicinchoninic acid. The BC assay is a colorimetric assay, 
which involves the reduction of Cu2+ ions to Cu+ ions by peptidic bonds present in 
proteins. Added bicinchoninic acid chelates Cu+ ions to form purple colored 
complexes, of which the optical absorbance is measured at 562 nm. Measured 
absorbance is proportional to the protein concentration in a linear range between 20 – 
2000 µg/ml. Protein concentration was calculated using references obtained from 
BSA standard protein ranging between 1 – 100 µg/ml (1, 2.5, 5, 15, 25, 40, 70, 100 
µg/ml). For the assay, the reagents were diluted in a ratio of A : B : C = 25 : 25 : 1. 
Protein samples were diluted 1 : 100, 1 : 200 or  1 : 1000 in water in a final volume 
100 µl. Duplicates of each sample were supplemented with 100 µl of the pre-mixed 
reagent in a 96 well plate. Water was used as a blanc reference. The mixtures were 
incubated at 37ºC for 30 minutes. Then, the absorbance was measured at OD 562 nm 
using an UV spectrophotometer (Tecan). Data analysis was performed using 
Microsoft Excel 2000 (version 9.0.8948 SP-3).     
 
3.5.3. Sodiumdodecylsulphate-polyacrylamide gel electrophoresis (SDS-PAGE) 
Sodiumdodecylsulphate-polyacrylamide gel electrophoresis (SDS-PAGE) was 
performed according to Laemmli (Laemmli, 1970). SDS-PAGE were run in minigel-
chambers (Biometra) with 1 mm spacers. Five % acrylamide stacking gels and 
separation gels of 6%, 7.5%, 8.5% or 10% acrylamide were prepared as given in 
Table V. Protein samples were mixed with 4x loading buffer and boiled for 5 minutes 
at 95ºC before they were loaded onto the gel. Proteins were separated for about 1h at 
80 – 120 V. Prestained protein-ladder (Fermantas) was used as molecular marker. The 
buffers recipes used in SDS-PAGE are listed below. 
  
SDS running buffer: 
SDS   0,1 % (w/v) 
Glycine                192 mM 
Tris base            25 mM 
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SDS sample buffer (4x): 
SDS    3,4 % (w/v) 
Tris HCl, pH 6,8   25 mM 
Glycerin                           2,4 % (v/v) 
 
Table V. Mixes for polyacrylamide gels  
 Stacking  
gel [µl]  
Separation 
gel [µl] 
   
 5% 6% 7.5% 8.5% 10% 
H2O 1405 3675 3853 3653 2772 
1.5 M Tris HCl pH 8.8 - 1750 1500 1500 1758 
0.5 M Tris HCL pH 6.8 625 - - - - 
30 % Acrylamide 425 1400 1500 1700 2331 
10 % SDS 25 70 70 70 70 
TEMED 2.5 7 7 7 7 
10% APS 25 70 70 70 70 
Mixes are for 1 gel 
 
3.5.4. Coomassie-blue-staining 
SDS gels or PVDF membranes after Western blot analysis (see chapter 3.5.4.), were 
stained with coomassie (Westermeier 1997) for 30-60 min. After that, nonspecific 
background was reduced by applying consecutive washing steps using destaining 
solution (10% acetic acid, 40% methanol).  
 
3.5.5. Western blot 
After protein separation on SDS-PAGE gels, as described in chapter 3.5.3., proteins 
were transfered onto PVDF membranes (Millipore) using semi-dry blot chambers 
(Pegasus). Protein transfer was performed in SDS blotting buffer (see below) at a 
constant current 150 mA for 90 – 150 minutes. Membranes were then blocked for 60 
minutes in 10% FCS in TBS-T or in 2% BSA in TBS-T. Membranes were then 
incubated with primary antibodies diluted in blocking solution for 60 minutes at room 
temperature or at 4ºC overnight. After that, the membranes were washed three times 
with three washing solutions (TBS-T, TBS-T/0.5 M NaCl, TBS-T/0.5 % Triton) for 
10 minutes each washing step. Then membranes were incubated with secondary 
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antibodies diluted in blocking solution for 60 minutes at room temperature. 
Membranes were washed again as described above and developed by applying 
Lumilight chemiluminescence substrate (Roche) for 2 minutes to the membranes 
followed by exposure to a film (Amersham Hyperfilm). Antibodies used for Western 
blot analysis are listed in Table VI. 
 
Table VI. List of primary antibodies used for Western blot analysis in this work 
Description Protein Type Dilution Source 
TUB2.1 β-tubulin  mouse 1:2000 Sigma Aldrich 
α3A2 α-tubulin mouse 1:50000 Biotem, France 
YL1/2 Tyr-tubulin rat supernatant Wehland et.al., 1983 
20C6 Tyr-tubulin mouse 1:5000 Wehland and Weber, 1987 
ID5 Glu-tubulin mouse supernatant Wehland and Weber, 1987 
L3 Glu-tubulin rabbit 1:5000 Paturle-Lafanechere et.al., 1994 
37B5D2 ∆2-Glu-tubulin rat 1:1000 SySy 
6-11B-1 acetylated-tubulin mouse 1:2500 Sigma-Aldrich 
H5-8 GFP rabbit 1:1000 HZI 
27F5 GFP mouse 1:1000 HZI 
αDSred mCherry rabbit 1:2500 Hans Faix, MH Hannover 
clone5 EB1 mouse 1:2500 BD Transduction Laboratories 
11B11 EB1 mouse 1:2500 Absea 
clone7 EB3 mouse 1:2500 BD Transduction Laboratories 
15H11 EBpan mouse 1:2500 Absea 
αDrf1 mDia1 rabbit 1:2000 Hans Faix, MH Hannover 
αDrf3 mDia2 rabbit 1:1000 Hans Faix, MH Hannover 
p140 mDia1 mouse 1:2000 BD Transduction Laboratories 
p150 p150Glued mouse 1:2000 BD Transduction Laboratories 
 
Table VII. List of secondary antibodies used for Western blot analysis in this work 
Name Description Dilution Coupled to Source 
A4c Goat anti-mouse IgG (H+L) 1:5000 HRP Dianova 
B4c Goat anti-rabbit IgG (H+L) 1:5000 HRP Dianova 
C4c Goat anti-rat IgG (H+L) 1:5000 HRP Dianova 
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List of buffers used for Western blot analysis: 
 
TBS: 
Tris-Base pH 7,6   20 mM 
NaCl    137 mM 
 
TBS-T: 
Tween 20 in TBS  0,1 % (v/v) 
 
Bloting buffer: 
Tris   50mM  
Glycine   39 mM 
SDS   0.037 (w/v)   
Methanol   20% (v/v) 
 
3.5.6. Purification of recombinant proteins from E. coli 
Expression of recombinant proteins was performed using E. Coli, BL 21 strains. 
pGEX-CLIP115 and pGEX-CLIP170 constructs (provided by Marco van Ham and 
Niels Galjart, Rotterdam, The Netherlands) containing the C-terminal parts of CLIP-
115 and CLIP-170 respectively fused to GST, were expressed, GST-fusion proteins 
were purified and subsequently used for immunization of rabbits. First, the constructs 
were transformed into E.coli according to the protocol described in chapter 3.2.9. 
Expression of recombinant proteins was then carried out according to standard 
protocols. For that, 7.5 ml of LB medium containing ampicillin was inoculated with a 
single colony and incubated overnight at 37ºC while shaking. The culture was then 
expanded to 800 ml in antibiotic-containing LB medium and incubated for another 3 
– 5 hours at 37ºC until OD600 reached 0.4. Protein expression was then induced by 
adding 0.1 mM IPTG to the culture and incubation at 37ºC was continued for 4 hours. 
After that, bacteria were centrifuged at 6000 x g for 15 min at 4ºC. Supernatant was 
discarded and harvested bacteria were then washed with 40 ml ice-cold 1x PBS. After 
centrifugation bacteria were resuspended in 64 ml 0.5% Triton X100 in 1 x PBS and 
subjected to two rounds of freeze/thawing. Then, bacteria were lysed by sonication, 
applying 3 pulses of 30 s each. The bacterial suspension was centrifuged at 12000 x g 
for 10 min at 4ºC and the supernatant was used for further isolation. Glutathione 
Material and Methods              
 53
Sepharose Beads 4B (GE Healthcare) were prepared as follows: 0.5 ml 75% slurry of 
Glutathione Sepharose Beads 4B was loaded onto a provided column and beads were 
washed with 200 ml ice-cold 1 x PBS. Bacterial supernatant was added to the beads 
supplemented with protease inhibitors (1 tablet, Roche) followed by incubation for 2 
hours or overnight at 4ºC on a rotary wheel to allow protein binding. Beads were then 
washed with 200 ml 1 x PBS. Proteins were eluted from the beads by addition of 1 ml 
elution buffer (50 mM Tris-HCl, 10 mM reduced glutathione, pH 8.0). Expression 
and purity of the proteins was confirmed by SDS-PAGE using samples from each 
purification step. Protein yield was assessed by SDS-PAGE using BSA standards 
ranging from 0.02 mg/ml to 1 mg/ml.         
 
3.5.7. G-LISA assays 
G-LISA assays were performed to measure the levels of active RhoA, Rac1 and 
Cdc42 in mouse embryonic fibrobasts. Experiments were carried out using 
commercially available G-LISA kits (Cytoskeleton) according to manufacturer’s 
protocol. In brief, 60-80 % confluent cells were lysed with lysis buffer and snapped 
frozen in liquid nitrogen. After thawing the samples, protein concentrations of the 
samples were equalized after protein concentration determination. Protein 
concentration determination was done using The Precision Red Advanced Protein 
Assay Reagent (Cytoskeleton). For that, 300 µl reagent was added to 10 µl of cell 
lysate in a 96-well plate. The mixture was incubated for 1 minute at room temperature 
and absorbance at 600 nm was measured in a microplate spectrophotometer (Tecan). 
Absorbance was then multiplied by 3.75 to obtain the protein concentration in mg/ml. 
Lysis buffer was used as a blanc reference. The protein lysates were subsequently 
applied on provided G-LISA plates containing Rho GTPase-GTP-binding proteins 
coupled to the wells and incubated for 15 – 30 minutes at 4ºC under agitation at 400 
rpm. Only active GTP-bound Rho GTPases bind to the wells while inactive GDP-
bound Rho GTPases do not. After incubation, plates were washed twice with washing 
buffer and were treated with antigen presenting buffer for exactly 2 minutes at room 
temperature. After three wash steps with washing buffer, the bound active Rho 
GTPase was detected with Rho GTPase specific antibodies, under agitation (400 rpm) 
for 30 – 45 minutes at room temperature. The plate was again washed three times and 
incubated with secondary HRP conjugated antibody for 30 – 45 minutes at room 
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temperature while shaking (400 rpm). After three wash steps the plate was incubated 
with HRP detection reagent for 5 – 15 minutes at 37ºC followed by addition of HRP 
Stop buffer to cease the reaction. The absorbance at 490 nm wavelength was 
measured using a microplate spectrophotometer (Tecan). The levels of active Rho 
GTPases obtained from wild type and TTL-deficient cell lysates were compared. 
Active RhoGTPase proteins provided by the kit were used as positive controls, and 
lysis buffer was used as a negative control.  
 
3.6.  Microscopy   
 
3.6.1. Immunofluorescence staining 
Immunofluorescence stainings were performed to visualize protein localization within 
fixed cells by using specific antibodies. Cells seeded and cultured on 12 mm 
coverslips were fixed according to a protocol adapted for +TIP detection. First, cells 
were washed once with 1 x PBS and fixed at -20ºC for 10 – 15 minutes in ice-cold 
methanol containing 1 mM EGTA. Coverslips were then transferred without rinsing 
to 4% formaldehyde in 1 x PBS and fixed for 15 – 20 minutes at room temperature. 
After that cells were washed with 1 x PBS and permeabilized for 10 minutes in 1 x 
PBS/0.15% Triton X-100. Cells were then blocked for 60 minutes in 1 x PBS/1% 
BSA/0.05% Tween20. Then, fixed cells were incubated with the first antibody diluted 
in blocking solution for 60 minutes at room temperature or overnight at 4ºC. Cells 
were washed three times for 10 minutes in 1 x PBS/0.05% and incubated for 60 
minutes at room temperature with the second antibody diluted in blocking solution. 
Again, cells were washed three times for 10 minutes in 1 x PBS/0.05% and then 
subsequently for 10 seconds in 1 x PBS, for 1 – 2 minutes in 70 % ethanol and for 1 
minute in 100% ethanol to dehydrate. Coverslips were then airdried, mounted in 
Mowiol (2.4 g mowiol, 6 g 87% glycerol, 0.2 ml 200mM Tris pH 8.5, 6 ml H2O) 
containing Anti-bleach (25 mg/ml n-propyl-gallate in 87% glycerol) and stored at 4ºC 
in the dark. Depending on the used antibodies, the standard protocol could be 
adapted. Primary and secondary antibodies used in this work are listed in Table VIII 
and IX, respectively.         
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Table VIII. List of primary antibodies used for immunofluorescence in this work 
Description Protein Type Dilution Source  
TUB2.1 β-tubulin  mouse 1:300 Sigma Aldrich 
α3A2 α-tubulin mouse 1:50000 Biotem, France 
YL1/2 Tyr-tubulin rat supernatant Wehland et.al., 1983 
20C6 Tyr-tubulin mouse 1:1000 Wehland and Weber, 1987 
ID5 Glu-tubulin mouse supernatant Wehland and Weber, 1987 
6-11B-1 acetylated-tubulin mouse 1:200 Sigma-Aldrich 
H110 Fascin rabbit 1:50 Santa Cruz 
55k2 Fascin mouse 1:50 Santa Cruz 
#2238 CLIP-115 rabbit 1:250 Hoogenraad, et.al., 2000 
#2163 CLIP-115 rabbit 1:1000 HZI 
#2360 CLIP-170 rabbit 1:250 Coquelle et al., 2002 
#2358 CLASP2 rabbit 1:300 Akhmanova et.al., 2001 
H5-8 GFP rabbit 1:500 HZI 
270F3 GFP mouse 1:1700 SySy 
clone5 EB1 mouse 1:2500 BD Transduction 
Laboratories 
11B11 EB1 mouse 1:200 Absea 
clone7 EB3 mouse 1:200 BD Transduction 
Laboratories 
15H11 EBpan mouse 1:200 Absea 
β-catenin β-catenin rabbit 1:50 Theresia Stradal 
p150 p150Glued mouse 1:200 BD Transduction 
Laboratories 
 
Cells were observed on an Axiovert 100TV (Zeiss) microscope with inverted optics, 
equipped with phase contrast and epifluorescence with appropriate filters for green, 
red or blue emission. Objective lenses 63x NA 1.4 and 100x NA 1.4 plan-
apochromatic were used. Images were acquired with a back-illuminated, cooled 
charge-coupled-device (CCD) camera (The Photometrics® CoolSNAPHQ2, Roper 
Scientific®, Inc.). Images were stored as 8- bit and 16-bit digital images and analyzed 
using Adobe Photoshop 9.0 software. 
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Table IX. List of secondary antibodies used for immunofluorescence in this work 
Name Description Dilution Coupled to Source 
A12c Goat anti-mouse IgG (H+L) 1:200 Alexa Fluor 488 Dianova 
A13c Goat anti-mouse IgG (H+L) 1:200 Alexa Fluor 594 Dianova 
A16c Goat anti-mouse IgG (H+L) 1:100 Alexa Fluor 350 Dianova 
B12c Goat anti-rabbit IgG (H+L) 1:400 Alexa Fluor 488 Dianova 
B13c Goat anti-rabbit IgG (H+L) 1:500 Alexa Fluor 594 Dianova 
B16c Goat anti-rabbit IgG (H+L) 1:200 Alexa Fluor 350 Dianova 
C12c Goat anti-rat IgG (H+L) 1:200 Alexa Fluor 488 Dianova 
C13c Goat anti-rat IgG (H+L) 1:200 Alexa Fluor 594 Dianova 
C16c Goat anti-rat IgG (H+L) 1:100 Alexa Fluor 350 Dianova 
 
 
3.6.2. Quantification of the length of microtubule plus-ends 
The length of microtubule plus-ends was quantified using ImageJ (version 1.32j) 
software by drawing lines along microtubules plus-ends and subsequently measuring 
their length using the option “measure” in panel “analyze”. The generated data files 
were imported and analyzed using Microsoft Excel 2000  (version 9.0.8948 SP-3) and 
SigmaPlot (version 8).     
 
3.6.3. Live cell imaging and analyzing microtubule dynamics 
For live cell imaging cells were seeded on 15 mm coverslips and transiently 
transfected with the mCherry-α-tubulin and MBD-GFP constructs (as described in 
chapter 4). Cells were imaged in an open chamber (Warner Instruments, Reading, 
UK) with a heater controller (model TC-324B) at 37°C using an Axiovert 100TV 
(Zeiss) inverted microscope equipped with EPI fluorescence lamp, electronically 
controlled shutters, filters and cooled CCD camera (see chapter 3.6.1.) controlled by 
MetaMorph software. Images were recorded at 2 seconds time interval using a 100x 
NA 1.4 plan-apochromatic objective lens. Cell culture medium was used and during 
live cell imaging the medium was exchanged every 30 minutes. Images were saved as 
“stack files” and analyzed using MetaMorph software. Movie sequences were 
subjected to a “low pass” filter in order to firmly expose microtubules and to reduce 
the background noise. Microtubule dynamics was analyzed by tracking microtubule 
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plus-ends of approximately 50 microtubules using MetaMorph “track points” 
function. Obtained data points were additionally analyzed in Microsoft Excel 2000 
(version 9.0.8948 SP-3). Growth and shortening rates were calculated as the 
instantaneous velocities for each pair of consecutive image frames and then the 
average speed of growing or shrinking microtubules was calculated. Transition events 
from pause to shortening (or growth) were only classified as catastrophes (or rescues) 
if growth (or shortening) preceded pause. The catastrophe (or rescue) frequency was 
defined as number of catastrophe (or rescue) events in single frame divided by the 
time microtubules spent growing (or shortening).  
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4. Results 
 
4.1. Influence of tubulin tyrosination on the localization of +TIPs 
 
4.1.1. Subcellular localization of microtubule plus end tracking proteins   
Subcellular localization of the most common +TIPs was analyzed in wild type and 
TTL-deficient mouse embryonic fibroblasts (MEFs). For that, cells were fixed and 
immunostained with antibodies directed against EB1, CLIP-170, CLIP115 and 
CLASP2. As shown in Figure 12A and B, EB1 revealed a normal comet-like 
localization at the microtubule plus end in both cell types, forming “comets” at the 
end of (growing) microtubules. It has been described that CAP-Gly domain-
containing proteins (like CLIP-170) bind specifically to tyrosinated microtubules and 
do not bind to microtubules that have the C-teminal tyrosine residue on α-tubulin 
removed as the result of tubulin detyrosination (128). Surprisingly and in contrast to 
published data, in our set-up CLIP-170 is localized at MT + ends both in TTL+/+ and 
TTL-/- MEFs independently of the tubulin tyrosination (Fig. 12C and D). Also, the 
MT plus end localization of CLIP-115 was affirmed regardless to the tyrosination 
status of microtubule (Fig. 12E and F), which is also in contrast to the published data. 
Additionally, as it was already shown in the PhD thesis of Andreas Fischer, a notable 
difference in the length of CLIP-115 decorated MT +ends between TTL+/+ and TTL-
/- MEFs was observed. This issue will be elaborated in detail in the further sections of 
this work. Finally, CLASP2 displays a slight plus end localization on microtubules 
and furthermore, perinuclear localization as well as microtubule lattice decoration in 
the lamella of migrating cells were obvious (Fig. 12G and H). 
 
4.1.2. Generation of +TIP-specific RNAi knock-down vectors 
The discovery of RNA interference and the development of several knock-down 
systems based on this widely abundant biological mechanism by which double-
stranded RNA (dsRNA) induces gene silencing by targeting complementary mRNA 
for degradation, have revolutionized the way of studying gene function in living cells. 
The commercially available pSuper.neo+GFP vector bearing the green fluorescent 
protein (GFP)-coding cassette (Fig. 13), which allows selection of transfected cells, 
turned out to be a useful tool for knock-down of genes of interest. In this study this 
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Figure 12. Localization of +TIPs in TTL+/+ and TTL-/- MEFs. Cells were fixed and 
immunostained using antibodies directed against EB1 (A, B), CLIP-170 (C, D), CLIP-115 (E, 
F) and CLASP2 (G, H). Clearly microtubule plus end localization was observed. Note the 
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difference in CLIP-115 microtubule plus end decoration between wild type and TTL-deficient 
cells. Multiple TTL+/+ and TTL-/- cell lines were used. Scale bar – 10 µm. 
  
vector is used for investigating the +TIPs localization patterns in the context of the 
TTL cycle in mouse embryonic fibroblasts (MEFs). Specific oligonucleotide 
sequences designed to target mRNA of distinc +TIPs were cloned into 
pSuper.neo+GFP vector. For all of the +TIPs studied in this work, two separate 
constructs with different oligosequences were used to ensure high specificity of the 
knock-down. Oligonucleotide sequences that have already been published (146, 150, 
162, 181) were used (see chapter 3.4.7.). After construct generation and sequence 
verification, functionality of the contructs was tested in B16 mouse melanoma cells. 
In all experiments the empty pSuper.neo+GFP plasmid was used as a negative 
control.           
    
 
 
 
Figure 13. Schematic representation of pSuper.neo+GFP RNAi.  Vector was used to clone 
the oligonucleotides for specific silencing of microtubule plus end binding proteins. For 
cloning the BgllII and HindIII restriction sites were used. (Adapted from pSUPER RNAi 
system manual – OligoEngine 2003)   
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Three to four days after transfection, cells were fixed and immunostained using 
specific antibodies detecting several +TIPs. All cloned RNAi contructs turned out to 
be functionally correct. The reduction of gene expression reached high level 
approximately 70 – 90%, which was visualized by immunofluorescence microscopy. 
The RNAi vectors were then used for transfection into wild type and TTL-deficient 
MEFs. Subsequently, localization of several +TIPs on microtbubule plus ends was 
compared using immunofluorescence microscopy. The results obtained by these 
RNAi experiments are described in the next chapters.              
 
4.1.3. CLIP-170 knock-down in MEFs   
CLIP-170 is the first discovered and one of the most studied plus end tracking 
proteins and is known to interact with many other +TIPs, like EB1, CLIP-115, 
CLASPs and Lis1 (18, 162). CLIP-170 can bind directly to MT +ends or through 
interactions with EB proteins (150, 152). Therefore, we analyzed how knock-down of 
CLIP-170 in MEFs might influence the binding of the other +TIPs in the context of 
tubulin tyrosination. 60 – 80 % confluent wild type and TTL-deficient MEFs were 
transfected with both CLIP-170 RNAi constructs and cells were fixed after 3 – 4 
days. Transfected EGFP-expressing cells were selected and analyzed by 
immunofluorescence microscopy using antibodies detecting CLIP-170 as well as 
CLIP-115, EB1 and CLASP2. In transfected TTL+/+ and TTL-/- MEFs CLIP-170 
was clearly no longer visible at MT +ends (Fig. 14B and 15B). In GFP-expressing 
cells, i.e. CLIP-170 knock-down, CLIP-115 proteins remained bound to the MT 
+ends in TTL+/+ and TTL-/- cells (Fig. 14D and 15D). Also, the localization of EB1 
proteins on microtubules in both TTL+/+ and TTL-/- MEFs after CLIP-170 knock-
down was unaffected (Fig. 14F and 15F). Finally, no changes in the localization of 
CLASP2 were noticed in CLIP-170 depleted TTL+/+ and TTL-/- MEFs (not shown). 
       
 
  
4.1.4. CLIP-115 knock-down in MEFs   
CLIP-115 belongs to the CAP-Gly domain-containing family of plus end tracking 
proteins and shows a high sequence homology to CLIP-170. CLIP-115 lacks the C-
terminal zinc binding domain that is present in CLIP-170 (18). Since CLIP-115 
interacts with CLIP-170, EB1 and CLASPs (18), we decided to analyze the 
localization of +TIPs in TTL wild type and TTL knock-out cells that were depleted 
from CLIP-115. For that, 60 – 80% confluent wild type and TTL-deficient MEFs  
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Figure 14. CLIP-170 knock-down in TTL+/+ MEFs. TTL+/+ cells (#67) were transfected with 
a CLIP-170 RNAi construct, fixed and immunostained using GFP (A,C,E) CLIP-170 (B), 
CLIP-115 (D) and EB1 (F) antibodies. GFP expressing cells clearly showed dislocalization of 
CLIP-170 (B), however this did not influence the localization of CLIP-115 (D) and EB1 (F). 
Scale bar – 10 µm.  
 
were transfected with both CLIP-115 RNAi constructs and cells were fixed after 3 – 4 
days. Cells were then immunostained using antibodies detecting CLIP-115 as well as 
CLIP-170, EB1 and CLASP2 to check their subcellular localization by 
immunofluorescence microscopy. 
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Figure 15. CLIP-170 knock-down in TTL-/- MEFs. TTL-/- cells (#59) were transfected with a 
CLIP-170 RNAi construct, fixed and immunostained using GFP (A,C,E) CLIP-170 (B), CLIP-
115 (D) and EB1 (F) antibodies. As for wild type cells (Figure 14), GFP expressing cells 
clearly showed dislocalization of CLIP-170 (B), however this did not influence the localization 
of CLIP-115 (D) and EB1 (F). Scale bar – 10 µm. 
 
In general, CLIP-115 depletion did not result in dislocalization of any of the other 
+TIPs tested, this observation is seen in both TTL+/+ and TTL-/- MEFs (Fig. 
16B,D,F and 17B,D,F). These results are similar to the results found in CLIP-170 
knock-down experiments. Thus, EB1, CLIP-170 and CLASP2 localization at MT+ 
ends is not affected by both CLIP-170 and CLIP-115 knock-down in wild type and 
TTL-deficient cells.  
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Figure 16. CLIP-115 knock-down in TTL+/+ MEFs. TTL+/+ cells (#67) were transfected with 
a CLIP-115 RNAi construct, fixed and immunostained using GFP (A,C,E) CLIP-115 (B), 
CLIP-170 (D) and EB1 (F) antibodies. GFP expressing cells clearly showed dislocalization of 
CLIP-115 (B), however this did not influence the localization of CLIP-170 (D) and EB1 (F). 
Scale bar – 10 µm.   
 
4.1.5.  CLASP2 knock-down in MEFs  
CLASP2 is a member of the basic/Serine-rich sequences-containing protein family 
and was initially identified as a CLIP-170 interacting protein (18, 180). CLASP2 can 
bind directly to microtubules and additionally can interact with EB1, CLIP-115 and 
CLIP-170 (18, 181). Since CLASP proteins are also prominent regulators of 
microtubule dynamics (181), we tested how tyrosination / detyrosination of  
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Figure 17. CLIP-115 knock-down in TTL-/- MEFs. TTL-/- cells (#59) were transfected with a 
CLIP-115 RNAi construct, fixed and immunostained using GFP (A,C,E) CLIP-115 (B), CLIP-
170 (D) and EB1 (F) antibodies. As for wild type cells (Figure 16), GFP expressing cells 
clearly showed dislocalization of CLIP-115 (B), however this did not influence the localization 
of CLIP-170 (D) and EB1 (F). Scale bar – 10 µm. 
 
microtubules would affect the binding of +TIPs to microtubules after CLASP2 
depletion. Since immunostaining of CLASP2 requires a different fixation protocol as 
for the other +TIPs, it was not possible to obtain double labeling of CLASP2 together 
with CLIPs or EB1. Therefore, the GFP-expressing and thus CLASP2-depleted MEFs 
were selected and analyzed for CLIPs and EB1 localization. As shown in Figure 
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18B,D,F and 19B,D,F, CLASP2 RNAi treatment, did not affect EB1 as well as CLIP-
170 and CLIP-115 localization on the MT +ends in both TTL+/+ or TTL-/- MEFs.  
 
 
 
Figure 18. CLASP2 knock-down in TTL+/+ MEFs. TTL+/+ cells (#67) were transfected with 
a CLASP2 RNAi construct, fixed and immunostained using GFP (A,C,E) CLIP-170 (B), CLIP-
115 (D) and EB1 (F) antibodies. CLASP2 knock-down did not influence the localization of 
CLIP-170 (B), CLIP-115 (D), and EB1 (F). Scale bar – 10 µm.  
      
 
4.1.6. EB knock-down in TTL+/+ and TTL-/- MEFs 
The EB family of microtubule plus end tracking proteins is comprised of the three 
closely related members EB1, EB2 and EB3. EB proteins are known to display 
microtubule plus end binding behavior independent of the presence of any other  
Results              
 67
 
 
Figure 19. CLASP2 knock-down in TTL-/- MEFs. TTL-/- cells (#59) were transfected with a 
CLASP2 RNAi construct, fixed and immunostained using GFP (A,C,E) CLIP-170 (B), CLIP-
115 (D) and EB1 (F) antibodies. As for wild type cells (Figure 18), CLASP2 knock-down did 
not influence the localization of CLIP-170 (B), CLIP-115 (D) and EB1 (F). Scale bar – 10 µm.   
 
+TIPs (150, 152). Moreover, EBs can interact with and recruit many other +TIPs to 
the microtubule plus ends by a mechanism known as “hitchhiking” (150, 152). EBs 
are also regulators of microtubule dynamics acting as potent stabilizer of growing 
microtubules (145). Because EB proteins seem to be the spider in the web at the MT 
+end, we decided to analyze the influence of EB protein depletion on the localization 
of other +TIPs. We have focused on the CLIP family of +TIPs. Moreover, the effects 
were analyzed in the background of TTL deficiency. As all three EB proteins can be 
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differentially expressed and can fulfill distinct functions in different cell types, first, 
the expression pattern of EB1, EB2 and EB3 were tested in mouse embryonic 
fibroblasts.  
 
 
Figure 20. EB expression in MEFs. A) Immunofluorescence staining of TTL-/- MEFs using 
anti-EB3 antibodies. Cells were fixed and immunostained using an anti-EB3 monoclonal 
antibody. No clear EB3 localization at the MT +ends was observed. Scale bar – 10 µm. B) 
Western blot analysis using an EB3 monoclonal antibody. Cell lysates from different cell 
types were used and are listed above the image. Last three lanes show brain lysates from 
TTL +/+, TTL-/- mice and a “+” - positive brain lysate control. EB3 protein corresponds to ~38 
kDa band. Obviously, no EB3 protein could be found in MEFs C) RT-PCR. cDNA from 
TTL+/+ and TTL-/- MEFs was isolated and analyzed by RT-PCR using specific primers for 
EB1, EB2, and EB3, and for actin as a positive control. PCR products of ~400 bp and ~350 
bp correspond to EB1 and EB2 respectively. EB3 mRNA could not be detected in TTL +/+ 
and TTL-/- MEFs. D) Gradient PCR. cDNA from TTL+/+ and TTL-/- MEFs was isolated and 
analyzed by RT-PCR using specific primers for EB2 and EB3. A range of 30°C annealing 
temperature (from 42.8 to 67.2°C) was applied and PCR products were analyzed on an 
agarose gel. EB3 mRNA transcripts could only be detected as a faint band in the lanes 
marked with a red arrow.  
 
By using EB1-specific primers in RT-PCR analysis, we found EB1 to be expressed in 
MEFs. No remarkable difference concerning mRNA levels between wild type and 
TTL-deficient MEFs was observed (Fig. 20C). Next, also EB2-specific mRNA was 
shown to be present in MEFs (Fig. 20C), however, using immunofluorescent 
microscopy, no specific EB2 localization could be observed (not shown). Finally, also 
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immunostaining using EB3-specific antibodies revealed no clear localization at 
microtubule plus ends (Fig. 20A) which is in contrast to published data (145, 150). To 
check these findings, Western blot analysis and RT-PCR were performed. Using total 
brain protein lysates obtained from the BD Biosciences as a positive control, wild 
type embryonic brain and TTL knockout brain it was clearly shown that EB3 protein 
is present as a ~38 kDa band in these lysates (Fig. 20C, lanes: brain lysates). In the 
same experiment obviously no EB3 protein is present in lysates derived from wild 
type and TTL-deficient MEFs (Fig. 20C, lanes: TTL+/+ and TTL-/-). Finally, 
although a very faint band was detected, RT-PCR analysis did not reveal the presence 
of EB3 specific mRNAs in MEFs (Fig. 20C and D). In conclusion, the fibroblasts 
used in this study do mainly express EB1. Both EB2 and EB3 turned out to be not 
detected at all, or at a very low level respectively. 
 
 
 
 
Figure 21. Knock-down of EB proteins in MEFs. TTL+/+ cells (#67) were transfected with 
EB1 or EB1/3 RNAi constructs, fixed and immunostained using GFP (A, C) and EB1 (B, D) 
antibodies. EB1-downregulated, GFP expressing cells show a clear reduction in EB1 
expression (B), whereas EB1/EB3-downregulated, GFP expressing cells still show clear EB1 
localization at microtubule plus ends (D). Scale bar – 10 µm.  
Results              
 70
To study the influence of EB proteins on the localization of the other +TIPs in the 
background of TTL-deficiency, RNAi knock-down was used to remove EB1 from 
MT +ends. Two sets of RNAi constructs, specific for EB1 and EB1/3, were used that 
supposed to result in the knock-down of EB1 and both EB1 and EB3 respectively. 
Because EB2 seems not to be present in our cell system, this protein was not further 
analyzed in this work. As described before, wild type and TTL-deficient MEFs were 
transfected with the different RNAi constructs. Cells were fixed after 3 – 4 days and 
immunostained using EB1-specific antibodies. EB1 RNAi construct-transfected cells 
were identified by the presence of GFP and in these cells, the amount of EB1 was 
reduced and dislocalized from MT +ends (Fig. 21A and B). In cells transfected with 
the constructs that should lead to EB1/EB3 double knock-down, EB1 was still present 
in the cells and still showed localization at the MT +ends, indicative for non-specific 
knock-down (Fig. 21C and D). For that reason the EB1/3 RNAi constructs were no 
longer used in this work. 
 
 
 
Figure 22. EB1 knock-down influences CLIP-170 localization in TTL+/+ and TTL-/- MEFs. 
TTL+/+ (#67) and TLL-/- (#59) MEFs were transfected with an EB1 RNAi construct, fixed and 
immunostained using EB1 (A, C) and CLIP-170 (B, D) antibodies. Transfected cells are 
marked by white arrows. EB1 knock-down leads to CLIP-170 dislocalization from MT +ends 
in both TTL+/+ and TTL-/- cells. The boxed regions are magnified and shown as insets 1 and 
2 at the right. Scale bar – 10 µm. 
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Figure 23. EB1 knock-down influences CLIP-115 localization in TTL+/+ and TTL-/- MEFs. 
A) TTL+/+ (#34) and TTL-/- (#33) MEFs were transfected with an EB1 RNAi construct, fixed 
and immunostained using EB1 (A, C) and CLIP-115 (B, D) antibodies. Transfected cells are 
marked by white arrows. Note: EB1 knock-down leads to CLIP-115 dislocalization from MT 
+ends only in TTL+/+ cells and not in TTL-/- cells. The boxed regions are magnified and 
shown as insets 1 and 2 at the right. Scale bar – 10 µm. B) Quantification of MT +ends 
length. CLIP-115 decorated MT +ends (<500 per condition) of cells treated as in A were 
measured. CLIP-115 comet length is significantly higher in TTL-/- cells. Statistical 
significance was assessed using student T test, *** - significant for p < 0,001. Bars on the 
chart show standard error of the mean (SEM).             
 
As the EB1 knock-down turned out to be effective, the localization of CLIP proteins 
in EB1-depleted TTL+/+ and TTL-/- MEFs was analyzed. Again, transfected cells 
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could be recognized by EGFP fluorescence. In both TTL+/+ and TTL-/- cells, CLIP-
170 was removed from microtubule plus ends upon EB1 knock-down (Fig. 22B and 
D), which is in line with published data (150). 
Next, CLIP-115 localization in EB1 depleted MEFs was analyzed. As seen for CLIP-
170, also CLIP-115 proteins were dislocalized from the MT +ends in TTL wild type 
cells after EB1 knock-down (Fig. 23B, panel A). In contrast, in TTL-deficient cells 
CLIP-115 remained present on the microtubule plus ends after EB1 knock-down (Fig. 
23D, panel A). Quantification revealed significant differences in the length of CLIP-
115 positive plus ends between TTL+/+ and TTL-/- MEFs. As it was already shown 
in the thesis of Andreas Fischer, in nontransfected cells, CLIP-115-decorated MT 
+ends were longer in TTL -/- MEFs compared to wild type cells (Fig. 12F). The 
length of CLIP-115 comets at microtubule plus ends in EB1-depleted TTL+/+ MEFs, 
that sometimes were still detectable, was much shorter then those in EB1-depleted 
TTL-/- MEFs (Fig. 23, panel B). Also the CLIP-115-decorated plus ends in EB1-
depleted wild type cells were significantly shorter as the CLIP-115 plus ends in 
nontransfected wild type cells (Fig. 23, panel B). The same was observed in TTL-/- 
MEFs, Also here the CLIP-115-MT plus end length was significantly shorter in EB1-
depleted cell compared to non-depleted cells. Furthermore, this difference was much 
smaller than that observed in TTL wild type MEFs (Fig. 23, panel B). Finally, the 
localization of CLASP2 was not affected by the knock down of EB1 in either wild 
type or TTL-deficient cells (not shown).    
                                             
4.1.7. Reconstitution of TTL in EB1-depleted TTL-/- MEFs 
Because a difference in binding behavior was observed for CLIP-115 in TTL+/+ and 
TTL-/- MEFs after EB1 knock-down, it was interesting to check whether it is possible 
to restore the CLIP-115 binding phenotype observed in TTL+/+ MEFs by re-
introduction of TTL protein in TTL-deficient cells. For that purpose, TTL rescue 
experiments were performed in TTL-/- MEFs together with EB1 knock-down. The 
TTL-/- MEFs were co-transfected with the EB1 RNAi construct and the pIRES2-
EGFP-TTL construct to simultaneously downregulate EB1 and overexpress TTL. 
After 3 – 4 days, cells were fixed and immunostained using antibodies directed 
against EB1, CLIP-115 and tyrosinated-tubulin. GFP expressing cells were selected 
and analyzed with respect to EB1, tyrosinated-tubulin and CLIP-115.  
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Figure 24. TTL rescue experiments. A) TTL-/- MEFs (#111) were cotransfected using EB1 
RNAi and pIRES2-EGFP-TTL constructs, fixed and immunostained using tyrosinated-tubulin 
Y1/2 (A), CLIP-115 (B) and EB1 (C) antibodies. An EB1 downregulated and TTL 
overexpressing cell is marked by white arrow. Cells only overexpressing TTL are marked by 
white arrowheads. EB1 knock-down together with TTL rescue leads to CLIP-115 
dislocalization from MT +ends in TTL-/- cells. The boxed regions are magnified and shown as 
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insets 1 to 3. Scale bar – 10 µm. B) Quantification of MT +ends length. CLIP-115 decorated 
MT +ends (<500 per condition) of cells treated as in A were measured. CLIP-115 comet 
length is significantly lower in EB1 downregulated rescued TTL-/- cells. Statistical significance 
was assessed using student T test, *** - significant for p < 0,001. Bars on the chart show 
standard error of the mean (SEM).              
 
In EB1-depleted (Fig. 24C, panel A), TTL-rescued TTL-/- MEFs (Fig. 24A, panel A), 
e.g. cells that lack EB1 but do contain tyrosinated tubulin, CLIP-115 protein is 
removed from microtubule plus ends (Fig. 24A,B,C arrow, panel A). This is in line 
with observations in TTL+/+ MEFs. In TTL-/- cells that only re-express TTL and 
were not subjected to EB1 knock-down, CLIP-115 was still present on microtubule 
plus ends (Fig. 24A,B,C arrowheads, panel A). Non-transfected TTL-/- MEFs still 
have EB1 and CLIP-115 at the MT plus ends. Again, in these cells, CLIP-115-
decorated plus ends were longer than those observed in TTL rescued cells which was 
assessed by microtubule plus end length quantification (Fig. 24, panel B). In some 
cases, CLIP-115 was still present at the microtubule plus ends of TTL-deficient cells 
that were reconstituted with TTL and were EB1-depleted. These reminiscent CLIP-
115 structures were most probably due to non-complete knock-down in these cells. 
We were thus able to restore the differences in CLIP-115 comet length at 
microtubules in TTL-deficient cells by reconstitution of TTL. 
         
4.1.8. Influence of the zinc-binding domain on CLIP-170 localization  
CLIP-170 and CLIP-115 share a high similarity in amino acid sequences and only the 
absence of the C-terminal zinc-binding domain in CLIP-115 is the most remarkable 
difference between those two proteins (18). The zinc-binding domain of CLIP-170 
interacts with its N-terminal CAP-Gly domain and thereby initiating a closed 
autoinhibited conformation that both ends of the protein are no longer accessible for 
the interactions with other proteins or organelles (18). Since a distinct localization of 
CLIP-115 on MT +ends was observed in TTL+/+ and TTL-/- MEFs, it was reasoned 
to test if this is simply due to the lack of zinc-binding domain in CLIP-115. To 
address this question a CLIP-170 construct that lacks the C-terminal zinc-binding 
domain was generated as a N-terminal GFP fusion protein. The pEGFP-CLIP170-∆C 
construct was amplified and its expression was verified using Western blot analysis 
on transfected B16 cell lysates (not shown). Subsequently, the generated construct 
was used to transfect TTL+/+ and TTL-/- MEFs to analyze its subcellular 
distribution. Transfected cells were fixed and immunostained with antibodies against 
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GFP and CLIP-170. EGFP-CLIP170-∆C as well as EGFP-CLIP-170-full length (used 
as a positive control) both localized to MT +ends. Obviously the MT plus ends  
 
 
Figure 25. EGFP-CLIP-170-∆C localization in TTL+/+ and TTL-/- MEFs. A) TTL-/- (#91) 
MEFs were transfected with EGFP-CLIP-170-∆C or EGFP-CLIP-170-fl constructs, fixed and 
immunostained with CLIP-170 (A, C) and GFP (B, D) antibodies. The boxed regions are 
magniefied and shown as insets 1 and 2 at the right. EGFP-CLIP-170-∆C binds stronger to 
MT +ends than EGFP-CLIP-170-full length. B) TTL+/+ (#110) and TTL-/- (#111) cells were 
transfected with EGFP-CLIP-170-∆C, fixed and immunostained for CLIP-170 (A, C) and GFP 
(B, D). The boxed regions are magnified and shown as insets 1 and 2 at the right. No 
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difference in EGFP-CLIP-170-∆C localization between TTL+/+ and TTL-/- MEFs could be 
observed. Scale bar – 10 µm. 
 
decorated with EGFP-CLIP170-∆C were longer (Fig. 25A, B, panel A) than those of 
EGFP-CLIP170-full length decorated MT plus ends (Fig. 25C, D, panel A). However, 
no difference in MT +ends length was observed when EGFP-CLIP170-∆C was 
overexpressed in either wild type (Fig. 25A, B, panel B) or TTL-deficient MEFs (Fig. 
25C, D, panel B). 
 
   
 
Figure 26. EGFP-CLIP-170-∆C localization in TTL+/+ and TTL-/- MEFs after EB1 knock-
down. TTL+/+ (#110) and TTL-/- (#111) MEFs were cotransfected with EB1 RNAi and 
EGFP-CLIP-170-∆C constructs, fixed and immunostained with EB1 (A, C) and CLIP-170 (B, 
D) antibodies. Transfected cells can be distinguished by the reduced EB1 plus end 
localization. The boxed regions are magniefied and shown as insets 1 and 2 at the right. No 
difference in localization of EGFP-CLIP-170-∆C could be observed in EB1-depleted TTL+/+ 
and TTL-/- cells. Scale bar – 10 µm. 
  
As shown above (chapter 4.1.6.), EB1 knock-down influenced the localization of 
CLIP-115 in different ways in TTL+/+ and TTL-/- cells. Therefore, the localization 
of EGFP-CLIP170-∆C in EB1 downregulated cells was tested. TTL+/+ and TTL-/- 
MEFs were co-transfected with the EB1 RNAi and EGFP-CLIP170-∆C constructs. 
After 3 – 4 days, cells were fixed and immunostained using EB1- and CLIP-170-
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specific antibodies. In EB1-depleted TTL+/+ and TTL-/- MEFs, EGFP-CLIP170-∆C 
was removed from MT +plus ends equally. Only very short CLIP-170 “comets” were 
obvious in both cell lines (Fig. 26B and D). In summary, EGFP-CLIP170-∆C protein 
showed the same microtubule plus end binding pattern in both TTL+/+ and TTL-/- 
MEFs that was not influenced by EB1-knock down, implicating that CLIP-170 
lacking the zinc-binding domain does not phenocopy CLIP-115 in this experimental 
set-up.     
                 
4.1.9. EGFP-CLIP-115/170 hybrid proteins as a tool to study MT +end binding 
behavior of CLIPs  
Because no differences were observed in the localization of C-terminal-deleted 
EGFP-CLIP-170 in TTL+/+ and TTL-/- MEFs, the difference in CLIP-115 binding 
pattern could not be simply accounted for the absence of the zinc-binding domain in 
this protein. To find out more about which part of CLIP-115 specifies the distinct 
localization of this protein to MT +ends, several GFP fusion constructs were 
generated comprising different parts of CLIP-170 and CLIP-115 in different 
combinations. Constructs were designed using homology blocks that were selected by 
sequence alignment of both proteins (Fig. 27). Constructs 1 – 5 contain N-terminally 
GPF fused CLIP-115 fragments followed by CLIP-170 parts. In contrast, constructs 6 
– 10 comprise N-terminal GFP fused to CLIP-170 parts followed by CLIP-115 parts. 
The newly generated constructs were tested by transfecting B16 cells followed by 
Western blot analysis of the cell lysates. The resulting bands corresponded to the 
molecular masses of the hybrid proteins (not shown), indicating that all constructs 
were properly expressed. Subsequently, these constructs were transfected into 
TTL+/+ and TTL-/- MEFs in order to analyze MT +end localization of the fusion 
proteins. Cells were fixed and immunostained with anti-GFP antibodies one day after 
transfection. Additionally cells were stained for tyrosinated tubulin to select TTL-/- 
cells without any tyrosinated tubulin. All ten EGFP-CLIP-115/170 hybrid proteins 
showed microtubule plus end localization. Cells that express high levels of these 
proteins revealed localization of these proteins along the entire microtubule lattice 
(not shown). Therefore, only cells with low expression levels of the fusion proteins 
were analyzed. Hybrid proteins 1 – 4 showed typical binding to microtubule plus ends 
in both TTL+/+ and TTL-/- MEFs (Fig. 28A – H). However, for the proteins 3 and 4 
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a slightly lower association with the plus ends was observed only in TTL+/+ MEFs 
(Fig. 28E and G). Fusion protein 5 showed a remarkable difference in binding to MT 
between TTL+/+ and TTL-/- MEFs. Whereas in TTL-/- cells this protein was 
typically localized to the MT +ends, in TTL+/+ cells only weak plus end binding was 
noticed and in many cells a complete removal of this protein from MT +ends was 
observed (Fig. 28I and J). Additionally, hybrid proteins 1 – 5 displayed remarkable 
perinuclear localization in both TTL+/+ and TTL-/- MEFs (Fig. 28A – J). The hybrid 
proteins 6 – 10, that lack the C-terminal zinc-binding domain, showed stronger MT 
+end binding resulting in longer “comets” (Fig. 28K – T). However, no differences in 
comet length were observed between the different proteins in both TTL+/+ and TTL-
/- MEFs. Only hybrid protein 8 revealed a slight weaker binding to MT +ends in both 
wild type and TTL-deficient MEFs (Fig. 28O and P). Furthermore, the proteins 6 – 10 
showed no obvious perinuclear localization, in contrast to the proteins 1 – 5.  
 
 
 
Figure 27. Schematic representation of EGFP-CLIP115/170 hybrid constructs. 
Schematic view of CLIP-115 (dark blue) CLIP-170 (light blue). Empty rectangles correspond 
to regions that are highly homologous between CLIP-115 and CLIP-170. Shown hybrids are 
numbered 1 to 10. Small numbers correspond to the respective base pairs in the cDNA. 
(Drawing by Marco van Ham)  
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Figure 28. Localization of EGFP-CLIP115/170 hybrids in TTL+/+ and TTL-/- MEFs. 
TTL+/+ (#189) and TTL-/- (#173) MEFs were transfected with the EGFP-CLIP115/170 hybrid 
constructs, fixed and immunostained with GFP antibodies. Numbers 1 – 10 correspond to the 
numbers as shown in Figure 27. For details see text. Scale bar – 10 µm. 
            
4.2. Microtubule dynamics  
 
4.2.1. mCherry-α-tubulin as a tool to study MT dynamics instability  
Tyrosinated and detyrosinated populations of microtubules can have different 
dynamic properties. Tyrosinated microtubules display a more dynamic behavior, 
whereas detyrosinated microtubules appear to be more stable (119 – 121). Since TTL 
deletion results in accumulation of detyrosinated tubulin and the reduction of 
tyrosinated tubulin in cells, it is tempting to analyze MT dynamics in TTL wild type 
and TTL-deficient MEFs. To measure these parameters mCherry-α-tubulin constructs 
were employed, enabling visualization of dynamic microtubules in live cells using 
EPI microscope-based live cell imaging techniques. Since mCherry-α-tubulin is 
tyrosinated and the lack of tyrosinated tubulin is a hallmark of TTL-/- cells, we 
decided to use also a detyrosinated version of mCherry-α-tubulin in TTL-/- cells. The 
newly generated mCherry-α-tubulin-∆Y construct was amplified and used for 
transfection of TTL-/- MEFs. First, microtubule-incorporating properties of mCherry-
α-tubulin proteins were tested. TTL+/+ and TTL-/- MEFs were transfected and fixed 
1 day after transfection. Cells were subsequently immunostained with anti-DSred 
antibody recognizing mCherry. Both mCherry-α-tubulin and mCherry-α-tubulin-∆Y 
proteins were properly incorporated into the microtubule in TTL+/+ and TTL-/- cells 
(Fig. 29, panel A), indicating that the fusion proteins are fully functional. To measure 
the parameters of microtubule dynamics, cells seeded on coverslips were transfected 
and subjected to live cell imaging one day later. As mCherry-α-tubulin constructs 
fully reproduce MT dynamics, it was possible to analyze growing as well as pausing 
and shrinking microtubules. The plus ends of microtubules were tracked and the 
distance that microtubules traveled over time was measured. In that way, it was 
possible to draw history plots showing typical dynamic behavior of a single 
microtubule, comprised of the phases of growing, pausing and shrinking (Fig. 29, 
panel B). 
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Figure 29. mCherry-α-tubulin analysis in TTL+/+ and TTL-/- MEFs. A) TTL+/+ (#67) and 
#107) and TTL-/- (#59 and #111) MEFs were transfected with mCherry-α-tubulin (A, B) or 
mCherry-α-tubulin-∆Y (C, D) constructs, fixed and immunostained with anti-DSred antibodies.  
Both mCherry-α-tubulin and mCherry-α-tubulin-∆Y assemble into microtubules. Scale bar – 
10 µm. B) Microtubule history plot. TTL+/+ cells were transfected with a mCherry-α-tubulin 
construct and microtubule dynamics were analyzed by live-cell imaging. Images were made 
every two seconds and the distance a microtubule plus end has traveled (µm) is plotted 
against time (s). The history plot shown here is representative for made movies showing 
phases or growth, shrinkage and pause.         
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Parameters for microtubule dynamics including: growth rate, shortening rate, 
catastrophe and rescue frequency as well as the times microtubules spent growing, 
pausing and shrinking were analyzed.   
 
Table X. Microtubule dynamics  
 
MEFs TTL-/- TTL+/+ TTL-/- TTL+/+ TTL-/- TTL+/+ 
Construct mCherry-tub∆Y mCherry-tub mCherry-tub/ EB1RNAi MBD-GFP 
Growth rate         
 
Mean (µm/min) 
                            
Median  (µm/min) 
 
 
 
5.1 
± 3.6 
3.9 
(n = 1271) 
 
 
6.4 
± 6.0 
4.4 
(n = 1146) 
 
 
7.6 
± 5.8 
6.1 
(n = 1720) 
 
 
5.8 
± 4.3 
4.4 
(n = 1486) 
 
 
4.6 
± 3.0 
3.9 
(n = 1277) 
 
 
4.4 
± 2.9 
3.9 
(n = 1245) 
 
 
3.6 
± 2.3 
2.8 
(n = 1256) 
Shortening rate   
 
Mean (µm/min) 
                            
Median  (µm/min) 
 
 
14.4 
± 13.2 
11.3 
(n = 400) 
 
 
12.0 
± 11.5 
7.8 
(n = 697) 
 
 
25.6 
± 20.7 
19.3 
(n = 228) 
 
 
13.7 
± 13.4 
9.2 
(n = 528) 
 
 
11.5 
± 10.3 
7.6 
(n = 370) 
 
 
8.0 
± 6,5 
6.2 
(n = 652) 
 
 
7.9 
± 6.0 
6.2 
(n = 619) 
Catastrophe  
frequency (s-1) 
0.285 
(n = 283) 
0.232 
(n = 325) 
0.294 
(n = 126) 
0.096 
(n = 102) 
0.372 
(n = 275) 
0.152 
(n = 201) 
0.124 
(n = 153) 
Rescue  
frequency (s-1) 
0.055 
(n = 140) 
0.106 
(n = 244) 
0.036 
(n = 125) 
0.040 
(n = 119) 
0.037 
(n = 94) 
0.072 
(n = 180) 
0.100 
(n = 269) 
Time spent:         
 
Growing (%) 
Pausing (%) 
Shortening (%) 
 
 
33.6 
55.9 
10.6 
 
 
31.5 
49.4 
19.1 
 
 
57.3 
35.6 
7.1 
 
 
35.6 
51.8 
12.8 
 
 
23.1 
70.2 
6.7 
 
 
25.1 
61.7 
13.2 
 
 
27.3 
59.3 
13.4 
Total time  
observed (min) 124 125 99 138 183 155 152 
Number of cells, 
microtubules 
9, 60 4, 50 5, 51 3, 45 2, 45 2, 50 2, 50 
                
TTL+/+ (#34 and #132) and TTL-/- (#33 and #133) MEFs were used for analysis. n, total 
number of events observed. ± indicates standard deviation (SD).  
 
In total, approximately 50 microtubules from distinct cells were analyzed per 
experiment. In TTL+/+ and TTL-/- cells transfected with mCherry-α-tubulin only 
slight differences in microtubule growth rates were observed, as the growth speed in 
TTL+/+ MEFs was slightly higher (Table X). A two-fold decrease in microtubule 
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shortening rate was observed in TTL-/- MEFs compared to TTL+/+ cells. No obvious 
differences in catastrophe frequency between the two cell lines were observed. 
However, rescue frequencies turned out to be increased in TTL-/- cells. Furthermore, 
microtubules in TTL-/- MEFs spent more time pausing and shrinking, and less time 
growing than TTL+/+ cells. TTL-/- cells overexpressing mCherry-α-tubulin-∆Y had 
slightly decreased MT growth rates and increased shortening rates compared to TTL-
deficient cells overexpressing mCherry-α-tubulin. Catastrophe frequencies were 
comparable in both mCherry-α-tubulin and mCherry-α-tubulin-∆Yexpressing TTL-
deficient cells, however, in contrast, rescue frequencies were decreased in TTL-/- 
MEFs transfected with mCherry-α-tubulin-∆Y compared to mCherry-α-tubulin-
transfected TTL-/- MEFs. Microtubules in mCherry-α-tubulin-∆Y-transfected TTL-/- 
MEFs spent even more time pausing and less time shortening than microtubules in 
mCherry-α-tubulin-transfected TTL-/- MEFs. 
 
4.2.2. Influence of EB1 on microtubule dynamics 
As described in chapter 4.1.1. and 4.1.6., CLIP-115 showed different localization in 
TTL-deficient MEFs compared to wild type MEFs. Moreover, EB1 downregulation 
affected CLIP-115 localization differently in wild type and TTL-/- MEFs. Since 
CLIP-115 might be a potent MT dynamic regulator acting as a rescue factor, it was of 
most interest to test how EB1 knock-down influences MT dynamics. To test this, 
TTL+/+ and TTL-/- cells were cotransfected with the EB1 RNAi construct together 
with mCherry-α-tubulin. 3 – 4 days after transfection cells were subjected to live cell 
imaging and subsequently MT instability parameters were analyzed. Only cells 
expressing both GFP and mCherry were selected to be analyzed. It turned out that in 
both TTL+/+ and TTL-/- EB1-depleted MEFs, the MT growth rate was slightly 
decreased than in the respective EB1-undepleted cells (Table X). A more than two-
fold decrease in shortening rate was observed in EB1-depleted TTL+/+ cells when 
compared to undepleted TTL+/+ MEFs. The MT shrinking rate of EB1-depleted and 
EB1-undepleted TTL-/- MEFs remained similar. EB1 knock-down did not affect 
rescue and catastrophe frequencies in TTL+/+ cells expressing mCherry-α-tubulin but 
caused a significant decrease in catastrophe and rescue frequencies in TTL-/- cells. 
The times that microtubules spent growing, pausing and shrinking were not obviously 
changed in TTL-/- cells upon EB1 knock-down. In contrast, a significant increase in 
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pausing time and decrease in growing time was observed in EB1-depleted wild type 
MEFs compared to EB1-undepleted MEFs.    
                                   
4.2.3. Measuring microtubule dynamics using a MBD-GFP construct 
The use of mCherry-α-tubulin can disturb the balance in total amount of tubulin in 
the cell and that might have a negative impact on the validity of measured 
microtubule dynamic parameters. To overcome this limitation, a different approach to 
study MT dynamics was carried out. The MAP4-derived microtubule binding domain 
(MBD) was used as a GFP fusion protein to study MT dynamics thereby avoiding any 
effect due to differences in intracellular tubulin levels.  
 
 
 
Figure 30. Localization of MBD-GFP in TTL+/+ and TTL-/- MEFs. TTL+/+ (#132) and TTL-/- 
(#133) MEFs were transfected with the MBD-GFP construct, fixed and immunostained using 
GFP, β-tubulin, tyrosinated-tubulin (YL1/2), acetylated-tubulin (6-11B-1), and glutamylated-
tubulin (1D5) antibodies. Clearly, the MBD-GFP fusion protein does localize to microtubules 
and does not influence the MT-organization and the level of tubulin pools. Scale bar – 10 µm. 
 
In order to check if the MBD-GFP protein is not influencing the different tubulin 
populations, TTL+/+ and TTL-/- MEFs were transfected and subsequently subjected 
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to immunofluorescence or Western blot analysis. The MBD-GFP protein localized to 
the entire microtubule and did not affect levels of acetylated-, glutamylated-, 
tyrosinated-tubulin nor β-tubulin levels in TTL+/+ and TTL-/- MEFs, as observed in 
microscopic analysis (Fig. 30). Also in Western blot analysis, no differences in the 
amount of tyrosinated-, glutamylated-, ∆2- and β-tubulin levels in either TTL+/+ or 
TTL-/- MEFs was observed (Fig. 31).  
 
 
 
Figure 31. The influence of MBD-GFP expression on tublin modifications. TTL+/+ (#132 
and #143) and TTL-/- (#133 and #136) MEFs were transfected with the MBD-GFP construct, 
lysed and subjected for Western blot analysis using GFP, β-tubulin, tyrosinated-tubulin 
(YL1/2), ∆2-tubulin (37B5D2) and glutamylated-tubulin (1D5) antibodies. Lysates from 
untransfected cells were used as negative controls. Obviously, MBD-GFP expression has no 
impact on the levels of posttranslationally modified tubulins in both TTL+/+ and TTL-/- cells. 
The MBD-GFP protein is recognized as a ~95 kDa band. The tubulins show a band at 55 
kDa. 
 
These results led us to anticipate that the MBD-GFP fusion protein would be a new 
tool to measure microtubule dynamics. To test that, the MBD-GFP construct was 
transfected into TTL+/+ or TTL-/- MEFs and cells were subjected to live cell imaging 
after 24 hours to measure the parameters of microtubule dynamics. In general, the 
MBD-GFP fusion protein led to a reduction of the growth and shortening rate of 
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microtubules in both TTL+/+ and TTL-/- cells compared to mCherry-α-tubulin-
transfected cells. Additionally, the catastrophe frequencies were decreased in MBD-
GFP transfected TTL+/+ and TTL-/- MEFs compared to cells expressing mCherry-α-
tubulin. Furthermore, the rescue frequencies were increased in TTL-/- cells and 
slightly decreased in TTL+/+ cells transfected with MBD-GFP compared to cells 
overexpressing mCherry-α-tubulin. Both in wild type and TTL-deficient MBD-GFP 
expressing cells, a remarkable increase in time microtubules spent pausing was 
noticed and furthermore a decrease in growing time was observed compared to cells 
transfected with mCherry-α-tubulin. Slight changes in the time microtubule spent 
shortening were also observed in both TTL+/+ and TTL-/- MEFs expressing MBD-
GFP, when compared to cells that express mCherry-α-tubulin. These results indicate 
that the MBD-GFP fusion protein unfortunately can not be used as a valuable tool for 
measuring MT dynamics in our cell system. 
  
 
4.3. Cross-talk between MTs and the actin cytoskeleton  
 
4.3.1. Aluminium fluoride (AlF4) treatment of MEFs  
Since it has been shown that microtubules can be coupled to and grow along actin 
filaments (21), the microtubule network may be influenced by the actin cytoskeleton. 
It has also been described that detyrosinated and tyrosinated tubulin populations have 
different dynamic features, as detyrosinated microtubules are usually more stable and 
tyrosinated microtubules show a more dynamic behavior (119 – 121). There is 
evidence that proteins, like small Rho GTPases that are involved in the regulation of 
the actin cytoskeleton could also play a role in the stabilization of microtubules (29, 
33, 189). Small Rho GTPases belong to the family of GTPases that encompass a large 
group of enzymes which bind GTP and undergo conformational changes as GTP is 
hydrolysed to GDP. They are involved in many critical biological processes and play 
an important role in signal transduction, protein biosynthesis, cell migration and 
differentiation. In order to test the influence of small Rho GTPases on the 
microtubule cytoskeleton in TTL+/+ and TTL-/- MEFs, cells were subjected to AlF4 
treatment, which results in non-specific activation of GTPases leading to the 
promotion of extensive lamellipodial protrusions. AlF4 treated cells were fixed and 
stained with antibodies against tubulin and several +TIPs, such as EB1, CLIP-170 
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and CLIP-115, to observe possible changes in microtubule organization and 
localization of +TIPs. The efficiency of the AlF4 was judged by actin-phalloidin 
staining (not shown). Clearly, after AlF4 treatment microtubules displayed a curly 
appearance and that these curly microtubule structures were decorated with EB1, 
CLIP-170 and CLIP-115 proteins. Obviously, EB1, CLIP-170 and CLIP-115 were 
associated along the entire length of microtubules (Fig. 32). This phenotype was not 
only observed for tyrosinated microtubules (e.g. in wild type cells) but also for 
detyrosinated microtubules and occurred in both TTL+/+ as well as in TTL-/- cell 
lines. Concluding, unspecific activation of the GTPases resulted in the TTL-
independent response leading to drastic changes in microtubule phenotype.   
 
 
 
Figure 32. AlF4 treatment in MEFs. TTL+/+ (#34) MEFs were treated with AlF4, fixed and 
immunostained with CLIP-115, CLIP-170 tyrosinated-tubulin (20C6) and EB1 antibodies. AlF4   
treatment clearly leads to changes in the microtubule shape and to decoration of the entire 
microtubules with the analyzed +TIPs. The boxed regions are magnified and shown as insets 
1 to 3 at the right. Scale bar – 10 µm. 
         
4.3.2. mDia1 expression levels in MEFs  
The establishment of microtubule stability can involve a RhoA-dependent pathway 
where mDia1 can act downstream of RhoA (29, 33, 189). Since TTL-/- and TTL+/+ 
cells contain microtubule populations conferring different stability levels, the levels 
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of protein expression and activity of components of the Rho-dependent microtubule 
stabilization pathway were analyzed in both cell types. Having specific mDia1 and 
mDia2 antibodies available, it was possible to test the expression levels of these 
proteins by Western blot analysis using cell lysates obtained from TTL+/+ and TTL-
/- MEFs. Obviously, mDia2 proteins were found to be not expressed in MEFs (not 
shown). In contrast, mDia1 is being expressed in both wild type and TTL-deficient 
MEFs. However, an obvious variation in mDia1 expression level was detected and no 
correlation between mDia1 expression level and the presence of the TTL was 
observed (Fig. 33).  
 
 
 
Figure 33. mDia1 expression levels in TTL+/+ and TTL-/- MEFs. TTL+/+ (#34, #107 and 
#110) and TTL-/- (#33, #103 and #111) MEFs were lysed and subjected for Western blot 
analysis using mDia1 antibodies. β-tubulin antibodies were used as a loading control. 
Obviously, mDia1 is expressed at different levels in MEFs (i.e. independently of TTL 
genotype). mDia1 protein is recognized as a ~140 kDa band. β-tubulin shows a band at 55 
kDa.  
              
4.3.3. Small Rho GTPase levels in MEFs 
Since a diverse expression level of mDia1 was observed in TTL+/+ and TTL-/- 
MEFs, it was tempting to test the levels the upstream RhoA regulator. Additionally, 
mDia1 can also mediate MT stabilization and the formation of actin stress fibers (28, 
29). Furthermore, it is published that Rac1 activity is enhanced in TTL-deficient 
neuronal cells (214). Cdc42, another small GTPase, is involved in many microtubule  
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Figure 34. Levels of activated small Rho GTPases in TTL+/+ and TTL-/- MEFs. TTL+/+ 
and TTL-/- MEFs were lysed and subjected to G-lisa assays to analyze RhoA, Rac1 and 
Cdc42 activity as described in chapter 3.5.7. The pooled results from several experiments on 
multiple TTL+/+ and TTL-/- MEF cell lines are shown. Error bars indicate standard deviation 
(SD).         
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based processes, such as MTOC reorientation (45) and mediates the formation of a 
common complex with Rac1, APC, CLIP-170 and actin (54). Moreover, Cdc42 plays 
a role in MT stabilization by triggering the recruitment of APC to microtubule plus 
ends via GSK3β inactivation (211). Together these observations connect Rho 
GTPases activity to microtubules. Therefore, activity assays of the small Rho 
GTPases were performed on cell lysates derived from TTL-/- and TTL+/+ MEFs (see 
chapter 3.5.7.). In all experiments, control conditions were included, in which serum-
starved cells were supposed to show basal decreased Rho GTPase activaton level. 
As shown in Figure 34, upper panel, RhoA levels are increased in TTL-/- cells 
compared to TTL+/+ cells, however a big variation between several tested cell lines 
was observed. Rac1 activity levels showed a slight tendency towards increased 
activity in TTL+/+ MEFs (Fig. 34, middle panel), which is in contrast to data 
obtained in TTL-deficient neurons (214). Finally, Cdc42 also showed a slight 
tendency to be more activated in TTL+/+ cells (Fig. 34, lower panel). In both Rac1 
and Cdc42 activation assay experiments serum starvation did not result in decreased 
levels of active GTPases which may be indicative for incorrect handling of the cells. 
Additionally, as seen for RhoA activation assays, a relative large variation between 
several tested cell lines was observed in the Rac1 and Cdc42 activity experiments.  
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5. Discussion 
 
Microtubules are one of the three components of cytoskeleton and are critical for cell 
division, intracellular transport, cell motility and polarization. Tyrosination and 
detyrosination of α-tubulin has a vital role in neuronal organization during embryonic 
development. As one of the microtubule posttranslational modifications, it can also 
have an influence on the localization of microtubule associated proteins. Microtubule 
plus end-tracking proteins (+TIPs) fulfill important functions, such as regulating 
microtubule dynamics by acting as anti-catastrophe factor. They also contribute to 
microtubule stabilization and play a role in positioning of the mitotic spindle during 
cell division. They are not only present in mammalian cells but also in lower 
eukaryotes, such as fungi and yeast. In this work multiple attempts have been made to 
address the subcellular distribution and the cellular roles of +TIPs with regard to the 
tubulin tyrosination / detyrosination cycle. RNAi approaches were used to study the 
localization of several +TIPs at microtubules. Using this strategy, our aim was to 
enlighten the hierarchy of binding of +TIPs to microtubules, and in addition it should 
reveal modes of interaction within the multiprotein complex situated at the 
microtubule plus end. Moreover, some of the prominent +TIPs, such as EB1 and 
CLIP-170, share the same EEY/F motif at the very C-terminus, which corresponds to 
the same motif at the C-terminus of α-tubulin. This can create many potential direct 
as well as indirect interactions between these proteins. How the entire protein 
complex at the microtubule plus end is intertwined still challanges to debate and this 
study contributes to the clarification of some issues within the microtubule field.       
 
5.1. RNAi knock-down of +TIPs in the context of TTL deficiency 
Obviously, CLIP-170 knock-down does not influence the localization of EB1, CLIP-
115 and CLASP2 in TTL+/+ and TTL-/- cells (Fig. 14 and 15). CLIP-170 is known to 
interact via its C-terminal zinc-binding domain to the CAP-Gly domains from CLIP-
115 (18). This interaction, however, is apparently not predominant and therefore the 
majority of CLIP-115 proteins is probably bound to the MT +ends via EB1 and not 
through CLIP-170. CLIP-170 does not influence binding of EB1 to MT +ends, which 
is in line with our expectations, since CLIP-170 is known to hitchhike on EB1 and not 
other way around (150). A small portion of EB1 protein could still bind to the C-
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terminus of CLIP-170. This interaction, however, could not have been detected, as 
depletion of CLIP-170 by RNAi did not result in any visible EB1 removal from MT 
+ends in TTL+/+ and TTL-/- MEFs. Although CLASP2 initially was identified as a 
CLIP-associating protein (180), no visible change in localization of CLASP2 upon 
CLIP-170 down-regulation in TTL+/+ and TTL-/- MEFs was observed. CLASP2 is 
known to bind not only through CLIP-170 to microtubules but also can bind 
microtubules directly, i.e. independent from other +TIPs. This direct binding is not 
only restricted to the MT +ends but can also occur on the entire length of the 
microtubule lattice (183). The direct association between CLASP2 and microtubules 
could explain the here observed CLASP2 localization at the microtubule plus ends 
after CLIP-170 knock-down. 
 
Like for CLIP-170, also for CLIP-115 no influence on the localization of other +TIPs, 
such as CLIP-170, EB1 and CLASP2 has been observed in both TTL+/+ and TTL-/- 
cells (Fig. 16 and 17). CLIP-115, which is a close homolog of CLIP-170 only lacking 
the C-terminal zinc-binding domain, is known to interact directly and, via an EB1-
dependent mechanism, indirectly to microtubules (164). As CLIP-170 can not interact 
with the C-terminus of CLIP-115, this could explain why knock-down of CLIP-115 
does not affect MT +end localization of CLIP-170. CLIP-115 knock-down also did 
not disturb the localization of EB1 on MT+ ends in our MEFs. These observations 
could be explained by the fact that CLIP-115, similar to CLIP-170, can hitchhike on 
EB1 but not vice versa. And additionally, since CLIP-115 is lacking the C-terminal 
zinc-binding domain, EB1 is not able to interact with CLIP-115 as described for 
CLIP-170. Also CLASP2 localization is not affected by CLIP-115 knock-down 
which could be explained in the same line as for CLIP-170 knock-down, i.e. due to 
the different modes of CLASP2 binding to microtubules.  
 
Finally, CLASP2 knock-down in TTL+/+ and TTL-/- cells did not affect the binding 
of CLIP-170, CLIP-115 and EB1 on MT +end (Fig. 18 and 19). Although CLASP2 is 
known to bind to CLIPs (180), it does not influence the microtubule plus end 
localization of these proteins, most probably because the majority of the CLIPs bind 
to microtubules via EB1 (150). Even if there is a modest CLASP2-dependent MT 
+end binding of CLIPs, it would most probably be masked by an EB1-dependent 
binding of CLIPs. Also EB1 localization at the microtubule plus end is not affected in 
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CLASP2 depleted MEFs, although CLASP2 is known to interact with EB1 (181). 
Most probably the vast majority of the EB1 molecules bind directly to MT +ends 
without any assistance of other +TIPs like for instance CLASP2. As in case of CLIP-
170, a small portion of EB1 might still possibly bind to microtubules via CLASP2. 
This interaction however, could not be detected by immunofluorescence staining, as 
CLASP2 knock-down did not result in a visible removal of EB1 from MT +ends in 
both TTL wild type and TTL-deficient cells.  
 
In none of the aforementioned knock-down experiments the lack of TTL influenced 
the observed subcellular localization of the tested +TIPs. This may be surprising since 
it is published that in mouse embryonic fibroblasts, the CAP-Gly domain-containing 
proteins, such as CLIP-170 and CLIP-115, are removed from MT+ ends in TTL-
deficient cells (128). In our experiments, we were not able repeat this phenotype, 
probably due to differences in the MEF cell systems used.    
 
The role of EB proteins, that are master regulators at the microtubule plus end (48), in 
the localization of the +TIPs was investigated in the background of TTL deficiency. 
We first tested which EB isoforms are expressed in our cell system. EB1, EB2 and 
EB3 expression and intracellular localization was tested in TTL+/+ and TTL-/- 
MEFs. Although EB2 is expressed in mammalian cells (215), by using 
immunofluorescent analysis we could not show EB2 in our MEFs (not shown). 
However, the presence of EB2 mRNA was detected by RT-PCR (Fig. 20C and D). 
EB2 is a not very well studied member of the EB family. EB2 is known to be 
expressed in chinese hamster ovary CHO-K1 cells (145, 150) as well as in HT0180 
and SW480 tumor cells (215) and so far, there has been no evidence that this protein 
is not expressed in MEFs. As expected, EB1 expression could be verified by RT-PCR 
as well as immunofluorescent assays in our wild type and TTL-deficient cells (Fig. 
20C and 21). Surprisingly, EB3 protein, which resembles EB1 function as a 
catastrophe-suppressor factor (145), was found not to be expressed in our MEFs. EB3 
expression could not be confirmed either by immunofluoresence  (Fig. 20A) nor by 
Western blot analysis (Fig. 20B). RT-PCR analysis though revealed the presence of 
EB3 transcripts on a very low level (Fig. 20D), indicative for a low EB3 expression 
level in MEFs. This could explain the lack of a clear EB3 localization pattern 
obtained by immunostaining and the lack of EB3 in Western blot analysis. Recently it 
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has been shown that EB3 is involved in muscle differentiation, where it is required 
for myoblast elongation and fusion. Furthermore, EB3 is required for the regulation 
of microtubule dynamics at the cell cortex in a murine myoblast cell line C2C12 
(146). These results directed us to focus on the effects of EB1 knock-down on the 
localization of the other +TIPs in our further experiments. 
EB1 knock-down efficiency was tested using EB1 and EB1/3 RNAi constructs. The 
EB1 RNAi construct turned out to work efficiently leading to an almost complete 
EB1 dislocalization from the microtubule plus ends. In contrast, the EB1/3 RNAi 
construct, which was supposed to down-regulate both EB1 and EB3 proteins, resulted 
only in partial reduction of EB1 expression and MT +end localization in MEFs. The 
reason for this is unclear but it could be explained by a possible lower efficiency of 
the RNAi mechanism when two different mRNAs need to be targeted. As only the 
EB1 RNAi construct was fully functional in EB1 depletion in our mouse embryonic 
fibroblasts, this construct was used in further experiments.  
 
CLIP-170 proteins were removed from MT +ends in both EB1-depleted wild type 
and TTL-deficient cells (Fig. 22 and 35). This finding is consistent with already 
published data, which showed that coordinated knock-down of EB1 and EB3 in 
CHO-K1 leads to the dissociation of CLIP-170 from MT +ends (150). As EB3 was 
found not to be expressed in our cell system (see above), it is not possible to judge 
whether EB3 knock-down also impairs CLIP-170 plus end localization in our system. 
The tyrosination / detyrosination status of tubulin did not have any influence on the 
localization of CLIP-170 upon EB1 knock-down. Since we also did not observe any 
differences in MT +end localization of CLIP-170 in untransfected wild type and TTL-
deficient MEFs, one can conclude that in both cell lines virtually all CLIP-170 
molecules are hitchhiking on microtubule bound EB1.  
 
The difference observed in removal of CLIP-115 proteins from MT +ends in TTL+/+ 
and TTL-/- cells after EB1 depletion is a hallmark in this work (Fig. 23 and 35). 
Although CLIP-115 is less studied, it is definitely important for cellular functioning 
as shown by the loss of function of this protein in the hereditary Williams Syndrome, 
specifically in the neurological symptoms of mental retardation in this disease (216 – 
218). The difference in binding of CLIP-115 to MT +ends is obvious in untransfected 
TTL+/+ and TTL-/- MEFs. The CLIP-115 decorated microtubule plus ends in TTL-/- 
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MEFs were longer then those in wild type cells. This observation is in disagreement 
with published data. Peris et al. claimed removal of CLIP-115 and other CAP-Gly 
domain-containing proteins from MT +ends in Tyr-negative TTL-/- MEFs (128). The 
reason for increased binding of CLIP-115 to detyrosinated microtubules in our 
experiments is not clear. Since the interactions between CAP-gly domain-containing 
proteins and the EEY/F C-terminal motif of α-tubulin have been extensively studied 
even at the atomic level (154), the lack of the C-teminal tyrosine residue of α-tubulin 
in TTL-/- cells therefore should rather lead to the inability of microtubule association 
by CAP-Gly domain-containing proteins like CLIP-115. However, recent 
biochemical studies show that CLIP-170 binds to both α- and β-tubulin and that this 
binding is not only limited to the acidic C-terminal tail of tubulin. Enzymatic removal 
of both α- and β-tubulin C-terminal tails resulted in a still significant affinity of 
CLIP-170 to MTs, indicating that CLIP-170 does have binding sites at microtubules 
in addition to the α-tubulin C-terminus (226). The increased binding of CLIP-115 in 
TTL-/- cells, thus, can not simply be explained by tubulin detyrosination. There are 
some indications that posttranslational modifications of CLIP-115 could cause the 
differences in MT +end binding of CLIP-115. It has already been described that 
efficient binding of CLIP-115 to microtubules is sensitive to phosphorylation and is 
not mediated by the microtubule binding region alone but additionally requires the 
presence of the basic/Serine-rich stretch (219). Andreas Fischer in his PhD thesis 
showed that CLIP-115 is less phosphorylated in TTL-/- cells and that this 
phosphorylation could regulate the binding of CLIP-115 to MT +ends, however, 
future experiments are required to confirm this hypothesis.  
CLIP-115 proteins were dislocalized from the MT +ends in wild type MEFs upon 
EB1 depletion, whereas they were still bound to MT +ends in TTL knock-out cells 
(Fig. 23 and 35). As already stated, the C-terminal EEY/F motif of EB1 is known to 
interact with the CAP-Gly domains of both CLIP-170 and CLIP-115, and most of the 
CLIP proteins bind to MT +ends via EB1 (150, 154). Therefore it is not surprising 
that down-regulation of EB1 causes dissociation of CLIP-115 from MT +end in wild-
type cells. Why the knock-down of EB1 did not result in dissociation of CLIP-115 
from microtubule plus ends in TTL-deficient MEFs is unclear. One reason could be a 
possible increased number of CLIP-115 binding sites on detyrosinated microtubules 
by which CLIP-115 would omit EB1 protein in binding to the +ends. Hypothesizing 
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in this direction, the knock-down of EB1 would not have any influence on CLIP-115 
plus end localization since CLIP-115 binding sites at the microtubule plus end are not 
affected. The possible existence of more CLIP-115 binding sites on detyrosinated MT 
+ends would also be consistent with previous observation, that in untransfected TTL-
deficient MEFs, CLIP-115 comets at the microtubule plus ends are longer than in 
wild type cells (Fig. 2E and F). Data obtained by the quantification of MT +end 
length revealed somewhat longer CLIP-115 comets at the microtubule plus ends in 
untransfected TTL-deficient MEFs compared to EB1-depleted TTL-deficient cells 
(Fig. 23, panel B). This observation suggests that still a small portion of the CLIP-115 
molecules is affected by EB1 RNAi. In EB1-depleted wild type cells the vast majority 
of CLIP-115 was deleted from MT +ends, however, some reminiscent CLIP-115 
decorated plus ends were still detectable as small dots (Fig. 23, panel A). This would 
suggest that in these cells still a small portion of CLIP-115 binds to MT +ends 
independently of EB1. However, this remaining portion of CLIP-115 at the 
microtubule plus ends in EB1-depleted wild type cells could also be the result of 
incomplete EB1 knock-down. 
The here described difference in CLIP-115 behavior can also not be simply attributed 
to increased availability of the CLIP-115 for microtubule binding, due to the lack of 
its C-terminal zinc-binding domains that are present in CLIP-170. Although the 
CLIP-115 resembling CLIP-170∆C mutant indeed showed pronounced +end binding 
compared to CLIP-170 full length proteins (Fig. 25), it did not show any difference in 
MT binding in wild type and TTL-deficient cells. Additionally, also EB1 knock-down 
did not result in differences in mislocalization of full length CLIP-170 and 
CLIP170∆C. The same CLIP-170 deletion construct also localized to microtubules in 
HeLa cells and this binding was also stronger than full length CLIP-170 (220). A 
possible role of CLIP-115 modification could also explain the observed phenotype, 
however, further studies are required to elucidate the kind of modifications and 
whether they act in concert or independently of each other. The above mentioned 
different phosphorylation pattern of CLIP-115 in TTL+/+ and TTL-/- MEFs needs 
further elaboration. Furthermore, one can not exclude possible EB1 posttranslational 
modifications playing a role, however, such modifications, except for EB1 
phosphorylation are not known yet.   
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Figure 35. Scheme showing EB1-dependent CLIP/MT binding in wild type and TTL-
deficient MEFs. In TTL+/+ and TTL-/- cells, both CLIP-170 and CLIP-115 bind to MT +ends 
(upper part). EB1 knock-down leads to CLIP-170 dislocalization from MT +ends in both 
TTL+/+ and TTL-/- cells and, in contrast, results in CLIP-115 dislocalization from MT +ends 
only in TTL+/+ and not TTL-/- cells (lower part). Dashed lines show the interactions of CLIPs 
that are in contrast to data published by Peris et al. (Ref. 128). See text for details. (Adapted 
from Akhmanova & Steinmetz 2008; Nature reviews, Molecular Cell Biology).   
 
The CLIP-115 dissociation from microtubule plus ends observed in TTL+/+ cells 
after EB1 knock-down was phenocopied in TTL-/- cells that were reconstituted with 
the TTL enzyme and simultaneously transfected with the EB1 RNAi construct. This 
was also reflected in MT +end length quantification. Clearly, the CLIP-115 plus end 
length was decreased in TTL-deficient cells transfected with the pIRES2-EGFP-TTL 
construct, and drastically reduced in TTL knock-out cells cotransfected with the 
pIRES2-EGFP-TTL and EB1 RNAi constructs (Fig. 22B). These experiments 
confirmed that the observed distinct CLIP-115 behavior in EB1-depleted MEFs is 
linked to the presence of TTL enzyme.  
Taken together, according to the model that we propose, CLIP-170 and CLIP-115 are 
localized at MT +ends mostly via EB1 and independently of MT tyrosination status 
(Fig. 35, upper panel). After EB1 knock-down, CLIP-170 is removed from MT +ends 
in both wild type and TTL-deficient cells, whereas CLIP-115 still remains bound to 
MT +ends in TTL knock-out cells (Fig. 35, lower panel).    
Discussion / Outlook              
 99
 
In order to define which part of the CLIP-115 sequence specifies the distinct CLIP-
115 plus end tracking behavior in TTL+/+ and TTL-/- cells, several hybrid constructs 
were generated. In these constructs CLIP-115 regions were exchanged with 
corresponding CLIP-170 fragments. Since all constructs do contain the CAP-Gly 
domains and the coiled coil domain involved in MT domains, all mutants localized to 
microtubules as expected, however in a variable mode (Fig. 28). The first five 
constructs contain the CLIP-170 C-terminal zinc-binding domain, which is 
responsible for its autoinhibition (18). This makes these fusion protein less accessible 
for binding to microtubules, therefore it is not surprising that the first five mutant 
proteins (1 – 5) conferred a weaker MT +end tracking compared to the last five 
mutants (6 – 10) which lack the C-terminal zinc-binding domains (Fig. 28). 
Interestingly, proteins 1 – 5 displayed additionally a clear perinuclear localization 
most probably marking the Golgi apparatus. Although CLIPs have originally been 
identified as cytoplasmatic linker proteins, mediating the interaction of cytoplasmic 
organelles (including endocytic and exocytic vesicles) with microtubules (221 – 223) 
there is no evidence of their direct interaction with the Golgi apparatus in vivo. On the 
other hand, CLIPs are known to interact with the C-terminus of CLASPs (18), 
proteins that associate with the Golgi apparatus. The apparent localization of the first 
five fusion proteins near or at the Golgi apparatus could thus be due to an indirect 
binding via CLASPs, thereby targeting CLIPs to the Golgi compartment. Moreover, 
CLIP-115 was cloned using an antibody that recognizes a dendritic lamellar body 
(DLB), an organelle that resembles the Golgi apparatus (224), which suggests its 
possible affinity to Golgi-like structures. CLIPR-59, another member of the CLIP 
protein family and thus possessing bona fide microtubule binding motifs, however, 
does not localize to microtubules. In contrast, CLIPR-59 binds to trans-Golgi network 
(225) implying a possible involvement of CLIPs in the regulation of Golgi function. 
 
Reduced MT +end binding of the protein encoded by construct number 5, that 
contains the N-terminal CLIP-115 part followed by the C-terminal part of CLIP-170 
(see scheme, Fig. 27), in TTL+/+ cells was observed. Also the binding of hybrid 
proteins 3 and 4 was a bit weakened in TTL+/+ compared to TTL-/- cells. It seems 
that the sequence stretch from 1476 bp to 2670 bp of CLIP-115 (Fig. 27) present in 
construct 5 causes decreased MT +end binding in TTL+/+ cells. On the other hand, 
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the sequence stretch 1462 – 2782 bp of CLIP-170, missing in construct 5 could have 
resulted in decreased binding of this protein to MT +ends in TTL+/+ cells. These 
fragments comprise three blocks that are homologous between CLIP-115 and CLIP-
170 (Fig. 27), therefore the analysis of the non-homologous parts between these 
blocks will shed a light on the mechanism of CLIP-115/microtubule association. This 
region is part of the central coiled coil domain, responsible for the dimerization of 
CLIPs, therefore it would also be interesting to address the question of dimerization 
in further studies on CLIP-115 MT +end binding. To support these conclusions, 
further studies and deeper sequence analysis as to which amino acid residues are 
exactly involved in the observed differences in MT +ends binding should be 
constructed. Performing substitution-mutagenesis of single amino acid residues 
would shed some light on this issue. Furthermore, it would also be interesting to 
analyze the binding behavior of these hybrid proteins in EB1-depleted wild type and 
TTL-deficient cells. 
 
5.2.  Microtubule dynamics 
Microtubule dynamics were analyzed in TTL+/+ and TTL-/- cells and some TTL-
dependent changes were found. The most important observed difference was a more 
than two-fold reduction in microtubule shortening rate in TTL knock-out cells (Table 
X). This finding is in line with published data, as detyrosinated tubulin-containing 
microtubules show increased stability (119 – 121), which could be reflected by a 
lowered MT-shrinking rate. In addition, rescue frequencies were increased in TTL -/- 
MEFs as compared to TTL+/+ MEFs, which is in line with data published by Peris et 
al. (135). Catastrophe frequencies were comparable, though very slight decrease in 
TTL-/- was observed, also consistently with published results (135). Furthermore, a 
slight decrease in growth rate was noticed in TTL-/- MEFs and this was even more 
pronounced in cells that expressed the mCherry-α-tubulin-∆Y variant. These 
observations favor the hypothesis that the growth speed is slower for more stable 
microtubules. These results are in contrast to published data, where no difference in 
growing and shrinking MT speed was reported (135). A big decrease in the time 
microtubules spent growing and increase in the time microtubules spent pausing were 
noticed in TTL-/- cells compared to TTL+/+. This observation would be in line with 
the assumption that stable detyrosinated microtubules are more paused and less 
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growing-prone. These observations, however, are in conflict with published data, in 
which microtubules in TTL-null cells spent more time growing and less time pausing 
than microtubules in TTL wild type MEFs (135). The apparent contradictions 
between our study and published data might be caused by the lower number of 
microtubules that were analyzed in the study from Peris et al., and that in that study 
analyzed microtubules were mostly restricted to the ones located within 10 µm from 
the leading edge. In our study, almost a double amount of microtubules was analyzed 
and the analyzed microtubules were not temporally and spatially restrained within the 
cell. Furthermore, in this study a detyrosinated mCherry-α-tubulin variant was used 
in TTL-deficient cells that would also contribute to the observed differences. The 
results obtained in this study reflect then more the in vivo situation, in contrast to the 
study from Peris et al., where only tyrosinated mCherry-α-tubulin variant was used in 
experiments, resulting in TTL-deficient cells being transformed again into the wild 
type cells. Finally, small differences in the used cell system could have an influence 
on MT dynamics.  
 
EB1 knock-down had a more prominent impact on microtubule dynamics in wild type 
MEFs compared to TTL-deficient cells. EB1-depletion led to a drastic reduction in 
shortening rate and a slight decrease in growth rate in wild type cells. In TTL-
deficient cells these values were not affected. Catastrophe frequency was slightly 
increased in TTL+/+ cells and remarkably decreased in TTL-/- cells upon EB1 
knock-down cells. Rescue frequencies remained the same in TTL+/+ cells but were 
decreased in TTL-/- cells upon EB1 knock-down. These observations are consistent 
with published data, in which YFP-CLIP-170 protein was used for analyzing 
microtubule dynamics in CHO-K1 cells (145). Moreover, a striking increase in time 
microtubules spent pausing and decrease in time microtubule spent growing was 
observed for TTL+/+ in EB1 knock-down conditions. These changes in MT 
dynamics, especially in EB1-depleted wild type cells, could be attributed to the lack 
of CLIP-115 and CLIP-170 on MT +ends due to EB1 depletion. CLIP-115 itself, 
being a rescue factor, thereby promoting microtubule growth, could play a role in the 
observed changes in microtubule dynamics in EB1-depleted wild type MEFs. In 
future experiments, it would be interesting to test whether CLIP-115 knock-down (in 
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combination with simultaneous EB1 or CLIP-170 depletion) in wild type MEFs can 
copy microtubule dynamics as observed in TTL-/- cells.   
 
Additionally, a MBD-GFP construct, containing the microtubule-binding domain 
from MAP4 protein, was tested as a new tool to analyze microtubule dynamics. 
Although the MBD-GFP fusion protein by itself did not affect the organization and 
the ratio in tubulin pools in wild type and TTL-deficient cells, it caused notable 
changes in microtubule dynamics in both cell types in comparison to mCherry-α-
tubulin. The binding of the MBD-GFP fusion protein to the microtubule lattice 
resulted in less dynamic microtubules in both TTL+/+ or TTL-/- MEFs. This was 
reflected by decreased growing and shrinking speed of microtubules and additionally 
by an increased time microtubules spent pausing as well as by a decreased time 
microtubules spent growing. This slow-down of MT dynamics might be caused by 
mechanical and physical confinements that could be imposed on microtubules due to 
MBD-GFP binding. In summary, this new MBD-GFP fusion protein can 
unfortunately not be used as a reliable tool for analyzing microtubule dynamics. 
 
5.3. Actin- and microtubule-regulating proteins 
The involvement of actin-regulating proteins in microtubule cytoskeletal organization 
in the context of the TTL cycle was tested using three different approaches. First, 
aluminium fluoride treatment was employed to check the general influence of 
unspecific activation of all GTPases on cell morphology and architecture of the 
microtubule cytoskeleton in wild type and TTL-deficient cells. AlF4 induced unusual 
frizzy shaped microtubules in both TTL+/+ and TTL-/- MEFs. Unexpectedly, a clear 
colocalization of EB1, CLIP-170 and CLIP-115 was observed with these 
morphologically changed microtubules. These proteins decorated the entire length of 
those curly microtubules. Whether this colocalization is due to direct interactions of 
these +TIPs with the microtubules remains unknown. It is well known that +TIPs can 
bind to the entire microtubule lattice especially when they are ectopically expressed 
(220). Speculating, it could also be possible that upon microtubule structural changes 
some additional binding sites for the +TIPs are created, which would lead to their 
increased recruitment to microtubules. So far, no evidence for the direct engagement 
of Rho GTPases in the regulation of +TIP function and their MT-localization is 
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described. However, some studies showed the involvement of mDia proteins, which 
are effectors of the small GTPase RhoA, in binding to the +TIPs. This however, is 
more associated with microtubule stabilization, as it is known that EB1 binds to mDia 
to stabilize microtubules downstream of RhoA (33, 189).  
 
The mDia protein pathway, involving Rho GTPase as an upstream regulator and EB1 
acting downstream of mDia, is a well proven pathway that leads to the formation of 
common complex of mDia1 with EB1 and APC and subsequently results in 
microtubule stabilization (33, 189). Due to the fact that microtubules in TTL-/- MEFs 
are detyrosinated and confer increased stability (this study and 119 – 121), it was of 
interest to study the mDia proteins in TTL+/+ and TTL-/- MEFs. Two isoforms of 
mDia are known (i.e. mDia1 and mDia2), however the activity of these two proteins 
is not sufficiently dissected. Both of them are reported to play a role in MT 
stabilization (33, 189, 104) and furthermore, mDia1 is involved in the cross-talk of 
microtubules and actin cytoskeleton (58). Expression levels of both mDia1 and 
mDia2 in our cell system were analyzed. Since we were not able to detect mDia2, the 
main focus in this study was turned to mDia1. The expression of mDia1 could be 
confirmed in our MEFs, however the expression level was independent from TTL 
activity. The reason for this variation in mDia1 expression is unclear and the role of 
this protein in the context of tubulin tyrosination / detyrosination cycle was not 
studied in more detail.    
 
The third approach in analyzing the role of actin/microtubule-regulating proteins in 
the context of the TTL cycle was to measure the activity levels of the small Rho 
GTPases RhoA, Rac1 and Cdc42. It is already described that these proteins influence 
the regulation and are implicated in the interplay between actin- and microtubule 
cytoskeleton (28, 29, 45, 54, 211). RhoA activity assays revealed increased levels of 
activated RhoA in TTL-/- cells. This is consistent with our expectations, since RhoA 
is known to trigger microtubule stabilization (33, 189, 104) and TTL-deficient cells 
do contain more stable microtubules (this study and 119 – 121). The observed 
tendency towards decreased Rac1 activity levels in TTL-deficient cells may be 
surprising and is in contrast to published data describing that Rac1 activity is 
increased in TTL-deficient neuronal cells (214). The activation of Rac1 promotes 
microtubule growth and stability by the inactivation of the potent microtubule 
destabilizer Op18/stathmin (35, 210). It is also known that microtubule growth 
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stimulates Rac1 activity to promote lamellipodial growth (38). In this study, 
decreased microtubule growth was found to be a feature of TTL-/- MEF-microtubules 
and considering that way, the decreased level of Rac1 in these cells would not be then 
surprising. Finally, we observed that the level of activated Cdc42 is slightly decreased 
in TTL-deficient MEFs. This would be surprising as Cdc42 is also reported to be 
involved in MT stabilization, triggering the GSK3β-dependent MT+ end localization 
of APC and the MTOC reorientation (45, 211, see chapter 2.7.). 
Additionally, one should also remember the observed variability between independent 
experiments using several different cell lines. In the here performed assays, 
immortalized cells with a much faster metabolism were used. The observed 
insufficient serum starvation, used as a control in Rac1 and Cdc42 activation 
experiments, could reflect the high basal GTPase activity even after serum starvation. 
Thus, in further experiments a higher number of cell lines needs to be tested and the 
use of primary cell lines should be taken into account. 
 
5.4. General concluding remarks 
The tubulin tyrosination / detyrosination cycle has proven its importance in proper 
neuronal track organization in the mammalian brain, ensuring the correct function of 
the complete nervous system. Maintaining undisturbed neuronal differentiation and 
functionality, which is reflected in proper alignment of neuronal layers during 
embryogenesis, seems to be one of the main tasks of tyrosination / detyrosination 
cycle. The processes that guarantee basic neuronal activities and neuronal 
development in respect to the TTL cycle can also be related to proper functionality of 
our fibroblast system. Thus changes caused by interfering with the tubulin 
tyrosination / detyrosination cycle in neurons, e.g. the early-death phenotype of TTL-
deficient neurons in mice, can be studied on the molecular level by analyzing similar 
abnormalities emerging in fibroblasts. Microtubule plus end tracking proteins have 
emerged as regulators of important microtubule-based processes like cell motility, 
intracellular transport, cell division and differentiation. In this study, a differential 
microtubule binding behavior of CLIP-115, a CAP-Gly domain-containing +TIPs, is 
reported in cells lacking the TTL enzyme and depleted from EB1 proteins. This effect 
was TTL-dependent, as reconstitution experiments caused reversion of this phenotype 
to the wild type situation. This phenotype is not dependent on a possible lack of 
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autoinhibition of CLIP-115, but more probably is rooted in the coiled coil domain in 
the central part of the protein. The lack of TTL enzyme also triggered changes in 
microtubule dynamics, greatly manifested in a significant decrease in microtubule 
shrinking speed as well as in an increase of time microtubules spent pausing and a 
decrease of time microtubules spent growing. The lack of TTL enzyme did not have 
any obvious effect on the expression of the RhoA GTPase effector mDia1 and only 
caused slight changes in the activation of small Rho GTPases. Further studies should 
focus on mapping the regions within CLIP-115 that are responsible for the difference 
in binding to microtubule plus ends in TTL knock-out cells thereby addressing the 
role of CLIP-115 proteins in the regulation of microtubule dynamics. The observed 
difference in CLIP-115 binding patterns might be the result of specific 
posttranslational modifications in the CLIP-115 polypeptide. Well-known 
modifications like phosphorylation, polyubiquitination, myristoylation or 
palmitoylation could potentially influence the CLIP-115 binding behavior. Future 
research should focus on answering the question whether CLIP-115 is differently 
modified in wild type and TTL-deficient cells. And if so, what kind of modifications 
are present and how are they coordinated. Addressing the cellular function of these 
modifications could provide detailed knowledge concerning the role of CLIP-115 in 
TTL knock-out cells. As mentioned before, recent observations already revealed that 
TTL deficiency influences the phosphorylation pattern of CLIP-115 and this probably 
has an impact on the MT +end tracking behavior of this protein. Further elaboration 
of the phosphorylation status of CLIP-115 for instance by directed mutagenesis 
should help in understanding the binding properties of CLIP-115 to microtubules. 
This, in combination with down-regulation of +TIPs like EB1 and CLIP-170 by using 
RNA interference in wild type as well as in TTL-deficient cells, would open a new 
direction in dissecting the binding hierarchy of the +TIPs at the microtubule plus 
ends.  
Moreover, a conditional knock-out approach to generate tissue-specific TTL deletion 
would facilitate the investigation of the molecular mechanism(s) involved in the 
dramatic neurological TTL knock-out phenotype in other cell types and in adult mice. 
Microtubule dynamics / properties are known to play an important role in the 
formation of the immunological synapse, the formation of the epithelial adhesion belt 
and in muscle cell differentiation (139, 146, 229, 230). Analyzing the effects of a 
TTL deletion in for instance B- and T-lymphocytes as well as in macrophages and 
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dendritic cells could provide more knowledge on a possible role of TTL in basic 
immunological processes, such as the antigen presentation and the organization of the 
immunological synapse. By creating a TTL-deficient epithelial cell line it would be 
possible to study the role of tyrosinated / detyrosinated microtubules in epithelial cell 
polarization and in the regulation of intercellular junction formation (e.g. the 
cadherin/catenin-containing adherens junctions). Finally, the creation of a TTL-
deficient myoblast cell lineage would open an interesting field towards understanding 
the role of the tubulin tyrosination cycle in muscle cell differentiation.                                          
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6. Abbreviations  
 
A    Ampere 
APC  adenomatous polyposis coli protein 
ATP   Adenosine triphosphate 
bp    base pairs 
BSA   bovine serum albumin 
cDNA   copy DNA 
CAP-Gly   Cytoskeleton-associated protein Glycine-rich domain 
CLASP   CLIP-associated protein 
CLIP   CAP-Gly domain containing linker protein 
Da   Dalton 
DMSO   dimethylsulfoxide 
DNA   desoxyribonucleic acid 
EB   end binding protein 
E. coli   Escherichia coli 
EDTA   Ethylene diamine tetraacetic acid 
EGTA   Ethylene glycol-bis(2-aminoethylether)-tetraacetic acid 
ELISA   enzyme-linked immunosorbent assay 
f-actin   filamentous actin 
FCS   fetal calf serum 
fl    full length 
GDP   Guanosine diphosphate 
GEF   guanine nucleotide exchange factor 
EGFP   Enhanced green fluorescence protein 
GAP                     GTPase activating protein 
GST   glutathione-S-transferase 
GTP   Guanosine triphosphate 
GFP   green fluorescent protein 
IF    immunofluorescence 
IP3   inositol triphosphate 
IPTG   Isopropyl-b-D-galactopyranoside 
µ    micro 
m    milli 
M    molar 
MAP   microtubule associated protein 
mc   monoclonal 
MT   microtubule 
MT +end   microtubules plus end 
l    liter 
mRFP   monomeric red fluorescent protein 
mRNA   messenger RNA 
Nap1   Nck associated protein1 
OD   optical density 
PAK1   p21 activated kinase 1 
PAGE   polyacrylamide-gel electrophoresis 
PBS   phosphate buffered saline 
pc    polyclonal 
+TIP   microtubule plus end tracking protein 
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PCR   polymerase chain reaction 
PIP3   phosphatidylinositol (3,4,5) triphosphate 
RNA   ribonucleic acid 
SDS   sodium dodecyl sulphate 
TAE   Tris-Acetate-EDTA-buffer 
TBCB   tubulin folding cofactor B 
TBCE   tubulin folding cofactor E 
TBS(T)   tris buffered saline (with Tween 20) 
Tris   Tris-(hydroxymethyl) aminomethane 
V    Volt 
v/v   volume per volume 
WB   Western blot 
w/v   weight per volume 
x g   times gravity 
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